0000715787false--12-31Q12023P1YP1Y33.3333.3333.33http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#InterestExpensehttp://fasb.org/us-gaap/2022#InterestExpense00007157872023-01-022023-04-0200007157872023-05-04xbrli:shares00007157872023-04-02iso4217:USD00007157872023-01-01iso4217:USDxbrli:shares00007157872022-01-032022-04-0300007157872022-01-0200007157872022-04-030000715787tile:ModularCarpetResilientFlooringRubberFlooringAndOtherFlooringRelatedMaterialMember2023-01-022023-04-02xbrli:pure0000715787tile:ModularCarpetResilientFlooringRubberFlooringAndOtherFlooringRelatedMaterialMember2022-01-032022-04-030000715787tile:InstallationOfCarpetAndOtherFlooringRelatedMaterialMember2023-01-022023-04-020000715787tile:InstallationOfCarpetAndOtherFlooringRelatedMaterialMember2022-01-032022-04-030000715787srt:AmericasMember2023-01-022023-04-020000715787srt:AmericasMember2022-01-032022-04-030000715787srt:EuropeMember2023-01-022023-04-020000715787srt:EuropeMember2022-01-032022-04-030000715787srt:AsiaPacificMember2023-01-022023-04-020000715787srt:AsiaPacificMember2022-01-032022-04-030000715787tile:SyndicatedFacilityAgreementMemberus-gaap:LineOfCreditMember2023-04-020000715787tile:SyndicatedFacilityAgreementMemberus-gaap:LineOfCreditMember2023-01-010000715787tile:SyndicatedFacilityAgreementMembertile:TermLoanMember2023-04-020000715787tile:SyndicatedFacilityAgreementMembertile:TermLoanMember2023-01-010000715787tile:SyndicatedFacilityAgreementMember2023-04-020000715787tile:SyndicatedFacilityAgreementMember2023-01-010000715787us-gaap:SeniorNotesMember2023-04-020000715787us-gaap:SeniorNotesMember2023-01-010000715787tile:TermLoanAndSeniorNotesMember2023-04-020000715787tile:TermLoanAndSeniorNotesMember2023-01-010000715787us-gaap:InterestRateSwapMember2020-12-020000715787us-gaap:InterestRateSwapMember2023-04-020000715787us-gaap:InterestRateSwapMember2023-01-010000715787us-gaap:InterestRateSwapMember2023-01-022023-04-020000715787us-gaap:CommonStockMember2023-01-010000715787us-gaap:AdditionalPaidInCapitalMember2023-01-010000715787us-gaap:RetainedEarningsMember2023-01-010000715787us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-010000715787us-gaap:AccumulatedTranslationAdjustmentMember2023-01-010000715787tile:AccumulatedGainLossNetDiscontinuedCashFlowHedgeParentMember2023-01-010000715787us-gaap:RetainedEarningsMember2023-01-022023-04-020000715787us-gaap:CommonStockMember2023-01-022023-04-020000715787us-gaap:AdditionalPaidInCapitalMember2023-01-022023-04-020000715787us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-022023-04-020000715787us-gaap:AccumulatedTranslationAdjustmentMember2023-01-022023-04-020000715787tile:AccumulatedGainLossNetDiscontinuedCashFlowHedgeParentMember2023-01-022023-04-020000715787us-gaap:CommonStockMember2023-04-020000715787us-gaap:AdditionalPaidInCapitalMember2023-04-020000715787us-gaap:RetainedEarningsMember2023-04-020000715787us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-04-020000715787us-gaap:AccumulatedTranslationAdjustmentMember2023-04-020000715787tile:AccumulatedGainLossNetDiscontinuedCashFlowHedgeParentMember2023-04-020000715787us-gaap:CommonStockMember2022-01-020000715787us-gaap:AdditionalPaidInCapitalMember2022-01-020000715787us-gaap:RetainedEarningsMember2022-01-020000715787us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-020000715787us-gaap:AccumulatedTranslationAdjustmentMember2022-01-020000715787tile:AccumulatedGainLossNetDiscontinuedCashFlowHedgeParentMember2022-01-020000715787us-gaap:RetainedEarningsMember2022-01-032022-04-030000715787us-gaap:CommonStockMember2022-01-032022-04-030000715787us-gaap:AdditionalPaidInCapitalMember2022-01-032022-04-030000715787us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-032022-04-030000715787us-gaap:AccumulatedTranslationAdjustmentMember2022-01-032022-04-030000715787tile:AccumulatedGainLossNetDiscontinuedCashFlowHedgeParentMember2022-01-032022-04-030000715787us-gaap:CommonStockMember2022-04-030000715787us-gaap:AdditionalPaidInCapitalMember2022-04-030000715787us-gaap:RetainedEarningsMember2022-04-030000715787us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-030000715787us-gaap:AccumulatedTranslationAdjustmentMember2022-04-030000715787tile:AccumulatedGainLossNetDiscontinuedCashFlowHedgeParentMember2022-04-030000715787us-gaap:RestrictedStockMember2023-01-022023-04-020000715787us-gaap:RestrictedStockMembersrt:MinimumMember2023-01-022023-04-020000715787srt:MaximumMemberus-gaap:RestrictedStockMember2023-01-022023-04-020000715787us-gaap:RestrictedStockMember2022-01-032022-04-030000715787us-gaap:RestrictedStockMember2023-01-010000715787us-gaap:RestrictedStockMember2023-04-020000715787us-gaap:RestrictedStockUnitsRSUMember2023-01-022023-04-020000715787us-gaap:RestrictedStockUnitsRSUMember2023-04-020000715787us-gaap:RestrictedStockUnitsRSUMember2023-01-010000715787us-gaap:PerformanceSharesMembersrt:MinimumMember2023-01-022023-04-020000715787us-gaap:PerformanceSharesMembersrt:MaximumMember2023-01-022023-04-020000715787us-gaap:PerformanceSharesMember2023-01-022023-04-020000715787us-gaap:PerformanceSharesMember2023-01-010000715787us-gaap:PerformanceSharesMember2023-04-020000715787us-gaap:PerformanceSharesMember2022-01-032022-04-030000715787us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-022023-04-020000715787us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2023-01-022023-04-020000715787us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2023-01-022023-04-020000715787srt:MinimumMember2023-01-022023-04-020000715787srt:MaximumMember2023-01-022023-04-020000715787srt:EuropeMember2023-01-022023-04-020000715787srt:EuropeMember2022-01-032022-04-030000715787tile:SalaryContinuationPlanMembercountry:US2023-01-022023-04-020000715787tile:SalaryContinuationPlanMembercountry:US2022-01-032022-04-030000715787tile:NoraDefinedBenefitPlanMember2023-01-022023-04-020000715787tile:NoraDefinedBenefitPlanMember2022-01-032022-04-030000715787us-gaap:OperatingSegmentsMembertile:AMSMember2023-01-010000715787us-gaap:OperatingSegmentsMembertile:AMSMember2023-01-022023-04-020000715787us-gaap:OperatingSegmentsMembertile:AMSMember2023-04-020000715787us-gaap:OperatingSegmentsMembertile:AMSMember2022-01-032022-04-030000715787tile:EAAAMemberus-gaap:OperatingSegmentsMember2023-01-022023-04-020000715787tile:EAAAMemberus-gaap:OperatingSegmentsMember2022-01-032022-04-030000715787tile:EAAAMemberus-gaap:OperatingSegmentsMember2023-04-020000715787tile:EAAAMemberus-gaap:OperatingSegmentsMember2023-01-010000715787us-gaap:OperatingSegmentsMember2023-04-020000715787us-gaap:OperatingSegmentsMember2023-01-010000715787us-gaap:CorporateNonSegmentMember2023-04-020000715787us-gaap:CorporateNonSegmentMember2023-01-010000715787srt:ConsolidationEliminationsMember2023-04-020000715787srt:ConsolidationEliminationsMember2023-01-010000715787us-gaap:AccruedLiabilitiesMember2023-03-142023-03-140000715787us-gaap:EmployeeSeveranceMembertile:A2021RestructuringPlanMember2023-01-010000715787tile:A2021RestructuringPlanMemberus-gaap:DeferredBonusMember2023-01-010000715787us-gaap:EmployeeSeveranceMembertile:A2021RestructuringPlanMember2023-01-022023-04-020000715787tile:A2021RestructuringPlanMemberus-gaap:DeferredBonusMember2023-01-022023-04-020000715787tile:AssetImpairmentAndOtherRelatedChargesMembertile:A2021RestructuringPlanMember2023-01-022023-04-020000715787us-gaap:EmployeeSeveranceMembertile:A2021RestructuringPlanMember2023-04-020000715787tile:A2021RestructuringPlanMemberus-gaap:DeferredBonusMember2023-04-020000715787tile:A2021RestructuringPlanMember2021-09-082021-09-080000715787us-gaap:EmployeeSeveranceMembertile:EAAAMemberus-gaap:OperatingSegmentsMembertile:A2021RestructuringPlanMember2023-04-020000715787tile:EAAAMemberus-gaap:OperatingSegmentsMembertile:A2021RestructuringPlanMemberus-gaap:DeferredBonusMember2023-04-020000715787tile:EAAAMembertile:AssetImpairmentAndOtherRelatedChargesMemberus-gaap:OperatingSegmentsMembertile:A2021RestructuringPlanMember2023-04-020000715787tile:EAAAMemberus-gaap:OperatingSegmentsMembertile:A2021RestructuringPlanMember2023-04-020000715787tile:EAAAMemberus-gaap:OperatingSegmentsMembertile:A2021RestructuringPlanMemberus-gaap:CostOfSalesMember2022-01-032022-04-030000715787tile:A2021RestructuringPlanMembersrt:MinimumMember2023-04-020000715787srt:MaximumMembertile:A2021RestructuringPlanMember2023-04-020000715787tile:A2021RestructuringPlanMember2023-04-020000715787us-gaap:SubsequentEventMember2023-04-032023-07-02

UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
Form 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended April 2, 2023

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 001-33994
INTERFACE INC
(Exact name of registrant as specified in its charter)
Georgia58-1451243
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1280 West Peachtree StreetAtlantaGeorgia30309
(Address of principal executive offices)(zip code)
Registrant’s telephone number, including area code:           (770) 437-6800          
Securities Registered Pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Stock, $0.10 Par Value Per ShareTILENasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Date File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerþAccelerated filer¨Non-accelerated filer¨Smaller reporting companyEmerging growth company¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes    No þ
Number of shares outstanding of each of the registrant’s classes of common stock, as of May 4, 2023:
ClassNumber of Shares
Common Stock, $0.10 par value per share58,013,224



TABLE OF CONTENTS
Page
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Table of Contents
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
INTERFACE, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEETS
(in thousands, except par values)
APRIL 2, 2023JANUARY 1, 2023
(UNAUDITED)
ASSETS
Current assets
Cash and cash equivalents$101,273 $97,564 
Accounts receivable, net147,759 182,807 
Inventories, net312,745 306,327 
Assets held for sale3,433 — 
Prepaid expenses and other current assets46,563 30,339 
Total current assets611,773 617,037 
Property, plant and equipment, net291,838 297,976 
Operating lease right-of-use assets80,226 81,644 
Deferred tax asset17,386 17,767 
Goodwill and intangibles, net162,890 162,195 
Other assets89,092 89,884 
 
Total assets$1,253,205 $1,266,503 
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable$85,640 $78,264 
Accrued expenses114,027 120,138 
Current portion of operating lease liabilities11,601 11,857 
Current portion of long-term debt10,216 10,211 
Total current liabilities221,484 220,470 
Long-term debt490,901 510,003 
Operating lease liabilities71,325 72,305 
Deferred income taxes39,213 38,662 
Other long-term liabilities63,253 63,526 
 
Total liabilities886,176 904,966 
 
Commitments and contingencies
 
Shareholders’ equity
Preferred stock, par value $1.00 per share; 5,000 shares authorized; none issued or outstanding at April 2, 2023 and January 1, 2023
— — 
Common stock, par value $0.10 per share; 120,000 shares authorized; 58,053 and 58,106 shares issued and outstanding at April 2, 2023 and January 1, 2023, respectively
5,805 5,811 
Additional paid-in capital246,001 244,159 
Retained earnings277,345 278,639 
Accumulated other comprehensive loss – foreign currency translation(133,845)(138,775)
Accumulated other comprehensive loss – cash flow hedge(450)(749)
Accumulated other comprehensive loss – pension liability(27,827)(27,548)
 
Total shareholders’ equity367,029 361,537 
 
Total liabilities and shareholders’ equity$1,253,205 $1,266,503 
See accompanying notes to consolidated condensed financial statements.
3

Table of Contents
INTERFACE, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
(in thousands, except per share data)
THREE MONTHS ENDED
APRIL 2, 2023APRIL 3, 2022
Net sales$295,792 $288,002 
Cost of sales199,919 181,203 
Gross profit95,873 106,799 
 
Selling, general and administrative expenses86,254 78,492 
Restructuring, asset impairment and other charges142 887 
Operating income9,477 27,420 
 
Interest expense8,505 6,850 
Other expense, net1,500 170 
 
Income (loss) before income tax expense(528)20,400 
Income tax expense186 7,107 
 
Net income (loss)$(714)$13,293 
 
Earnings (loss) per share – basic$(0.01)$0.22 
Earnings (loss) per share – diluted$(0.01)$0.22 
 
Common shares outstanding – basic58,079 59,248 
Common shares outstanding – diluted58,079 59,248 
See accompanying notes to consolidated condensed financial statements.
4

Table of Contents
INTERFACE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
(in thousands)
THREE MONTHS ENDED
APRIL 2, 2023APRIL 3, 2022
Net income (loss)$(714)$13,293 
Other comprehensive income (loss), after tax:
Foreign currency translation adjustment4,930 (13,184)
Reclassification from accumulated other comprehensive loss – discontinued cash flow hedge299 641 
Pension liability adjustment(279)1,539 
Other comprehensive income (loss)4,950 (11,004)
Comprehensive income$4,236 $2,289 
See accompanying notes to consolidated condensed financial statements.
5

Table of Contents
INTERFACE, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(in thousands)
THREE MONTHS ENDED
APRIL 2, 2023APRIL 3, 2022
OPERATING ACTIVITIES:
Net income (loss)$(714)$13,293 
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:
Depreciation and amortization9,991 10,670 
Stock compensation amortization expense3,004 2,182 
Deferred income taxes and other599 4,196 
Amortization of acquired intangible assets1,283 1,342 
Working capital changes:
Accounts receivable35,791 26,135 
Inventories(5,306)(56,464)
Prepaid expenses and other current assets(16,148)(5,252)
Accounts payable and accrued expenses1,084 (13,798)
 
Cash provided by (used in) operating activities29,584 (17,696)
 
INVESTING ACTIVITIES:
Capital expenditures(5,712)(4,781)
 
Cash used in investing activities(5,712)(4,781)
 
FINANCING ACTIVITIES:
Repayments of long-term debt(53,225)(44,729)
Borrowing of long-term debt34,000 48,500 
Tax withholding payments for share-based compensation(1,167)(398)
Finance lease payments(643)(479)
 
Cash (used in) provided by financing activities(21,035)2,894 
 
Net cash provided by (used in) operating, investing and financing activities2,837 (19,583)
Effect of exchange rate changes on cash872 (1,581)
 
CASH AND CASH EQUIVALENTS:
Net increase (decrease)3,709 (21,164)
Balance, beginning of period97,564 97,252 
 
Balance, end of period$101,273 $76,088 
See accompanying notes to consolidated condensed financial statements.
6

Table of Contents
INTERFACE, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
References in this Quarterly Report on Form 10-Q to “Interface,” “the Company,” “we,” “our,” “ours” and “us” refer to Interface, Inc. and its subsidiaries or any of them, unless the context requires otherwise.
As contemplated by the Securities and Exchange Commission (the “Commission”) instructions to Form 10-Q, the following footnotes have been condensed and, therefore, do not contain all disclosures required in connection with annual financial statements. Reference should be made to the Company’s year-end financial statements and notes thereto contained in its Annual Report on Form 10-K for the fiscal year ended January 1, 2023, as filed with the Commission.
The financial information included in this report has been prepared by the Company, without audit. In the opinion of management, the financial information included in this report contains all adjustments necessary for a fair presentation of the results for the interim periods. All such adjustments are of a normal recurring nature unless otherwise disclosed. Nevertheless, the results shown for interim periods are not necessarily indicative of results to be expected for the full year. The January 1, 2023, consolidated condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States (“GAAP”).
The three-month periods ended April 2, 2023 and April 3, 2022 both include 13 weeks.
Risks and Uncertainties
Global economic challenges, including the impact of the COVID-19 pandemic, the war in Ukraine, inflation and supply chain disruptions could cause economic uncertainty and volatility. The Company considered these impacts and subsequent general uncertainties and volatility in the global economy on the assumptions and estimates used herein. In connection with the Cyber Event discussed below, security breaches may expose us to fines and other liabilities to the extent sensitive data stored in our IT systems, including data related to customers, suppliers or employees, are misappropriated. These uncertainties could result in a future material adverse effect to the amounts reported within the Company’s consolidated condensed financial statements if actual results differ from these estimates.
Cybersecurity Event
On November 20, 2022, we discovered a cybersecurity attack, perpetrated by unauthorized third parties, affecting our IT systems. Promptly, out of an abundance of caution, we shut down certain systems including shipping, inventory management and production systems and engaged forensic experts to evaluate the extent of the Cyber Event and its impact to our operations. We took steps to supplement existing security monitoring, including scanning and protective measures, and notified law enforcement.
Recently Adopted Accounting Pronouncements
In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-03, “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” This ASU clarifies that a contractual restriction on the sale of an equity security is not considered in measuring fair value. The ASU also requires certain disclosures for equity securities subject to contractual sale restrictions. The new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company adopted this standard on April 2, 2023. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.
7

NOTE 2 – REVENUE RECOGNITION
Revenue from sales of modular carpet, resilient flooring, rubber flooring, and other flooring-related material was approximately 98% and 99% of total revenue for the three-month periods ended April 2, 2023 and April 3, 2022, respectively. The remaining 2% and 1% of revenue was generated from the installation of carpet and other flooring-related material for the 2023 and 2022 three-month periods, respectively.
Disaggregation of Revenue
For the three months ended April 2, 2023 and April 3, 2022, revenue from the Company’s customers is broken down by geography as follows:
Three Months Ended
GeographyApril 2, 2023April 3, 2022
Americas57.2 %54.4 %
Europe32.0 %32.6 %
Asia-Pacific10.8 %13.0 %
Revenue from the Company’s customers in the Americas corresponds to the AMS reportable segment, and the EAAA reportable segment includes revenue from the Europe and Asia-Pacific geographies. See Note 11 entitled “Segment Information” for additional information.
8

NOTE 3 – INVENTORIES
Inventories are summarized as follows:
April 2, 2023January 1, 2023
(in thousands)
Finished goods$224,665 $209,478 
Work-in-process19,236 15,463 
Raw materials68,844 81,386 
Inventories, net$312,745 $306,327 

9

NOTE 4 – EARNINGS PER SHARE
The Company computes basic earnings (loss) per share (“EPS”) by dividing net income (loss) by the weighted average common shares outstanding, including participating securities outstanding, during the period as discussed below. Diluted EPS reflects the potential dilution beyond shares for basic EPS that could occur if securities or other contracts to issue common stock were exercised, converted into common stock or resulted in the issuance of common stock that would have shared in the Company’s earnings (loss).
The Company includes all unvested stock awards that contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, in the number of shares outstanding for basic EPS as these awards are considered participating securities. Any unvested stock awards considered non-participating securities are included in diluted EPS calculations when the inclusion of these shares would be dilutive. Unvested share-based awards of restricted stock are paid dividends equally with all other shares of common stock. As a result, the Company includes all outstanding restricted stock awards in the calculation of basic and diluted EPS. Distributed earnings include common stock dividends and dividends earned on unvested share-based payment awards. Undistributed earnings represent earnings that were available for distribution but were not distributed. The following table shows the computation of basic and diluted EPS:
Three Months Ended
April 2, 2023April 3, 2022
(in thousands, except per share data)
Numerator:
Net income (loss)$(714)$13,293 
Less: distributed and undistributed earnings available to participating securities(9)(190)
Distributed and undistributed earnings (loss) available to common shareholders$(723)$13,103 
 
Denominator:
Weighted average shares outstanding57,177 58,403 
Participating securities902 845 
Shares for basic EPS58,079 59,248 
Shares for diluted EPS58,079 59,248 
 
Basic EPS$(0.01)$0.22 
Diluted EPS$(0.01)$0.22 
For the three months ended April 2, 2023, 1,728,579 non-participating securities that could potentially dilute basic EPS in the future, consisting of restricted share units and performance shares, were excluded from the computation of diluted EPS as these securities would have been antidilutive for the period.
10

NOTE 5 – LONG-TERM DEBT
Long-term debt consisted of the following:
April 2, 2023January 1, 2023
Outstanding Principal
Interest Rate(1)
Outstanding Principal
Interest Rate(1)
(in thousands)(in thousands)
Syndicated Credit Facility:
Revolving loan borrowings$9,360 5.18 %$24,250 5.29 %
Term loan borrowings197,597 6.14 %202,082 5.84 %
Total borrowings under Syndicated Credit Facility206,957 6.10 %226,332 5.78 %
5.50% Senior Notes due 2028300,000 5.50 %300,000 5.50 %
 
Total debt506,957 526,332 
Less: Unamortized debt issuance costs(5,840)(6,118)
 
Total debt, net501,117 520,214 
Less: Current portion of long-term debt(10,216)(10,211)
 
Total long-term debt, net$490,901 $510,003 
(1) Represents the stated rate of interest, without the effect of debt issuance costs.
Syndicated Credit Facility
The Company’s Syndicated Credit Facility (the “Facility”) provides to the Company U.S. denominated and multicurrency term loans and provides to the Company and certain of its subsidiaries a multicurrency revolving credit facility. Interest on base rate loans is charged at varying rates computed by applying a margin depending on the Company’s consolidated net leverage ratio as of the most recently completed fiscal quarter. Interest on SOFR-based and alternative currency loans and fees for letters of credit are charged at varying rates computed by applying a margin over the applicable SOFR rate or alternative currency rate, depending on the Company’s consolidated net leverage ratio as of the most recently completed fiscal quarter. In addition, the Company pays a commitment fee per annum (depending on the Company’s consolidated net leverage ratio as of the most recently completed fiscal quarter) on the unused portion of the Facility.
As of both April 2, 2023 and January 1, 2023, the Company had $1.6 million in letters of credit outstanding under the Facility.
As of both April 2, 2023 and January 1, 2023, the carrying value of the Company’s borrowings under the Facility approximated its fair value as the Facility bears interest rates that are similar to existing market rates.
Under the Facility, the Company is required to make quarterly amortization payments of the term loan borrowings, which are due on the last day of the calendar quarter.
The Company is in compliance with all covenants under the Facility and anticipates that it will remain in compliance with the covenants for the foreseeable future.
5.50% Senior Notes due 2028
The 5.50% Senior Notes due 2028 (the “Senior Notes”) bear an interest rate at 5.50% per annum and mature on December 1, 2028. Interest is paid semi-annually on June 1 and December 1 of each year. The Senior Notes are unsecured and are guaranteed, jointly and severally, by each of the Company’s material domestic subsidiaries, all of which also guarantee the obligations of the Company under its Facility.

11

As of April 2, 2023, the estimated fair value of the Senior Notes was $244.1 million, compared with a carrying value recorded in the Company’s consolidated condensed balance sheet of $300.0 million, excluding unamortized debt issuance costs. The fair value of the Senior Notes is derived using quoted prices for similar instruments and is considered Level 2 within the fair value hierarchy.
The Company is in compliance with all covenants under the indenture governing the Senior Notes and anticipates that it will remain in compliance with the covenants for the foreseeable future.
Debt Issuance Costs
Debt issuance costs associated with the Company’s Senior Notes and term loans under the Facility are reflected as a reduction of long-term debt in accordance with applicable accounting standards. As these fees are expensed over the life of the outstanding borrowing, the debt balance will increase by the same amount as the fees that are expensed. As of April 2, 2023 and January 1, 2023, the unamortized debt issuance costs recorded as a reduction of long-term debt were $5.8 million and $6.1 million, respectively.
Debt issuance costs related to the issuance of revolving debt, which include underwriting, legal and other direct costs, net of accumulated amortization, were $1.7 million and $1.8 million as of April 2, 2023 and January 1, 2023, respectively. These amounts are included in other assets in the Company’s consolidated condensed balance sheets. The Company amortizes these costs over the life of the related debt.
12

NOTE 6 – DERIVATIVE INSTRUMENTS
Interest Rate Risk Management
From time to time, the Company enters into interest rate swap transactions to fix the variable interest rate on a portion of its term loan borrowing in order to manage a portion of its exposure to interest rate fluctuations. The Company’s objective and strategy with respect to these interest rate swaps is to protect the Company against adverse fluctuations in interest rates by reducing its exposure to variability to cash flows relating to interest payments on a portion of its outstanding debt.
Cash Flow Interest Rate Swaps
In the fourth quarter of 2020, the Company terminated its designated interest rate swap transactions with a total notional value of $250 million. Hedge accounting was also discontinued at that time. Losses recorded in accumulated other comprehensive loss for these terminated interest rate swaps are reclassified and recorded in the consolidated condensed statements of operations to the extent it is probable that a portion of the original forecasted transactions related to the portion of the hedged debt repaid will not occur by the end of the originally specified time period. See Note 14 entitled “Items Reclassified From Accumulated Other Comprehensive Loss” for additional information.
As of April 2, 2023 and January 1, 2023, the remaining accumulated other comprehensive loss associated with the terminated interest rate swaps, before tax, was $0.6 million and $1.0 million, respectively, and will be amortized to earnings over the remaining term of the interest rate swaps prior to termination. We expect that approximately $0.6 million, before tax, related to the terminated interest rate swaps will be reclassified from accumulated other comprehensive loss as an increase to interest expense in the next 12 months.


13

NOTE 7 – SHAREHOLDERS’ EQUITY
The following tables depict the activity in the accounts which make up shareholders’ equity for the three months ended April 2, 2023 and April 3, 2022:
SHARESCOMMON STOCKADDITIONAL PAID-IN CAPITALRETAINED
EARNINGS
PENSION LIABILITYFOREIGN CURRENCY TRANSLATION ADJUSTMENTCASH FLOW
HEDGE
(in thousands)
Balance, at January 1, 202358,106 $5,811 $244,159 $278,639 $(27,548)$(138,775)$(749)
Net loss— — — (714)— — — 
Issuances of stock related to performance shares79 (8)— — — — 
Cash dividends declared, $0.01 per common share
— — — (580)— — — 
Compensation expense related to stock awards, net of forfeitures and shares received for tax withholdings(132)(14)1,850 — — — — 
Pension liability adjustment— — — — (279)— — 
Foreign currency translation adjustment— — — — — 4,930 — 
Reclassification out of accumulated other comprehensive loss – discontinued cash flow hedge— — — — — — 299 
Balance, at April 2, 202358,053 $5,805 $246,001 $277,345 $(27,827)$(133,845)$(450)
SHARESCOMMON STOCKADDITIONAL PAID-IN CAPITALRETAINED
EARNINGS
PENSION LIABILITYFOREIGN CURRENCY TRANSLATION ADJUSTMENTCASH FLOW
HEDGE
(in thousands)
Balance, at January 2, 202259,055 $5,905 $253,110 $261,434 $(53,888)$(100,441)$(2,722)
Net income— — — 13,293 — — — 
Restricted stock issuances303 30 3,966 — — — — 
Unamortized compensation expense related to restricted stock awards— — (3,996)— — — — 
Cash dividends declared, $0.01 per common share
— — — (592)— — — 
Compensation expense related to stock awards, net of shares received for tax withholdings(30)(2)1,787 — — — — 
Pension liability adjustment— — — — 1,539 — — 
Foreign currency translation adjustment— — — — — (13,184)— 
Reclassification out of accumulated other comprehensive loss – discontinued cash flow hedge— — — — — — 641 
Balance, at April 3, 202259,328 $5,933 $254,867 $274,135 $(52,349)$(113,625)$(2,081)
Restricted Stock Awards
During the three months ended April 2, 2023, no restricted stock awards were granted. Awards of restricted stock (or a portion thereof) vest with respect to each recipient over a one to three-year period from the date of grant, provided the individual remains in the employment or service of the Company as of the vesting date. Additionally, certain awards (or a portion thereof) could vest earlier in the event of a change in control of the Company or upon involuntary termination without cause. For certain restricted stock awards with a graded vesting schedule, the Company has elected to recognize compensation expense on a straight-line basis over the requisite service period for the entire award.
Compensation expense related to restricted stock grants was $1.4 million and $1.2 million for the three months ended April 2, 2023 and April 3, 2022, respectively. The Company has reduced its expense for any restricted stock forfeited during the period.
14

The following table summarizes restricted stock outstanding as of April 2, 2023, as well as activity during the three months then ended:
Restricted SharesWeighted Average
Grant Date
Fair Value
Outstanding at January 1, 20231,006,400 $13.91 
Granted— — 
Vested(270,000)15.15 
Forfeited or canceled(6,800)13.54 
Outstanding at April 2, 2023729,600 $13.45 
As of April 2, 2023, the unrecognized total compensation cost related to unvested restricted stock was $4.2 million. That cost is expected to be recognized by the first quarter of 2025.
Restricted Share Unit Awards
During the three months ended April 2, 2023, the Company granted awards for 586,500 restricted share units to certain employees pursuant to the Company’s 2020 Omnibus Stock Incentive Plan. Each restricted share unit represents one share of the Company’s common stock to be issued to the award recipient once the vesting criteria have been satisfied. Awards of restricted share units have a graded vesting schedule over a three-year period from the date of grant, with one-third of the restricted share units vesting on each of the first, second and third anniversaries of the date of grant, provided the individual remains in the employment or service of the Company until such anniversaries. Additionally, certain awards (or a portion thereof) could vest earlier in the event of a change in control of the Company, upon involuntary termination without cause, or upon retirement provided certain eligibility criteria are met.
The Company recognizes expense related to restricted share unit grants based on the grant date fair value of the units awarded, as determined by the market price of the Company’s common stock at date of grant. The expense is captured in selling, general and administrative expenses in the consolidated condensed statements of operations, and the Company has elected to recognize compensation expense on a straight-line basis over the requisite service period for the entire award for awards with a graded vesting schedule.
Compensation expense related to the restricted share units was $0.5 million for the three months ended April 2, 2023. The Company reduces its expense for any restricted share units forfeited during the period. Grants of restricted share units are made primarily to executive-level personnel at the Company and, as a result, no compensation costs have been capitalized.
The following table summarizes restricted share units outstanding as of April 2, 2023, as well as activity during the three months then ended:
Restricted Share UnitsWeighted Average
Grant Date
Fair Value
Outstanding at January 1, 2023— $— 
Granted586,500 10.39 
Vested— — 
Forfeited or canceled— — 
Outstanding at April 2, 2023586,500 $10.39 
As of April 2, 2023, the unrecognized total compensation cost related to unvested restricted share units was $5.6 million. That cost is expected to be recognized by the end of 2026.

15

Performance Share Awards
During the three months ended April 2, 2023 and April 3, 2022, the Company issued awards of performance shares to certain employees. These awards vest based on the achievement of certain performance-based goals over a performance period of one to three years, subject to (among other things) the employee’s continued employment through the last date of the performance period, and will be settled in shares of our common stock or in cash at the Company’s election. The number of shares that may be issued in settlement of the performance shares to the award recipients may be greater (up to 200%) or lesser than the nominal award amount depending on actual performance achieved as compared to the performance targets set forth in the awards. The Company evaluates the probability of achieving the performance-based goals as of the end of each reporting period and adjusts compensation expense based on this assessment.
The following table summarizes the performance shares outstanding as of April 2, 2023, as well as the activity during the three months then ended:
Performance SharesWeighted Average
Grant Date
Fair Value
Outstanding at January 1, 2023923,600 $13.91 
Granted467,500 10.79 
Vested(79,400)15.16 
Forfeited or canceled(169,700)15.13 
Outstanding at April 2, 20231,142,000 $12.36 
Compensation expense related to the performance shares was $1.1 million and $1.0 million for the three months ended April 2, 2023 and April 3, 2022, respectively. The Company has reduced its expense for any performance shares forfeited during the period. Unrecognized compensation expense related to these performance shares was approximately $9.0 million as of April 2, 2023. Depending on the performance of the Company, any compensation expense related to these outstanding performance shares will be recognized by the end of 2026.
The tax benefit recognized with respect to restricted stock, restricted share units and performance shares was approximately $0.3 million for the three months ended April 2, 2023.
16

NOTE 8 – LEASES
General
The Company has operating and finance leases for manufacturing equipment, corporate offices, showrooms, distribution facilities, design centers, as well as computer and office equipment. The Company’s leases have terms ranging from 1 to 20 years, some of which may include options to extend the lease term for up to 5 years, and certain leases may include an option to terminate the lease. Our lease accounting may include these options to extend or terminate a lease when it is reasonably certain that we will exercise that option.
The Company records a right-of-use asset and lease liability for leases extending beyond one year for operating and finance leases once a contract that contains a lease is executed and we have the right to control the use of the leased asset. The right-of-use asset is measured as the present value of the lease obligation. The discount rate used to calculate the present value of the lease liability was the Company’s incremental borrowing rate for the applicable geographical region.
As of April 2, 2023, there were no significant leases that had not commenced.
The table below represents a summary of the balances recorded in the consolidated condensed balance sheets related to the Company’s leases as of April 2, 2023 and January 1, 2023:
April 2, 2023January 1, 2023
Balance Sheet LocationOperating LeasesFinance LeasesOperating LeasesFinance Leases
(in thousands)
Operating lease right-of-use assets$80,226 $81,644 
 
Current portion of operating lease liabilities$11,601 $11,857 
Operating lease liabilities71,325 72,305 
Total operating lease liabilities$82,926 $84,162 
 
Property, plant and equipment, net$5,838 $5,845 
 
Accrued expenses$2,173 $2,101 
Other long-term liabilities4,050 4,138 
Total finance lease liabilities$6,223 $6,239 
Lease Costs
Three Months Ended
April 2, 2023April 3, 2022
(in thousands)
Finance lease cost:
Amortization of right-of-use assets$655 $517 
Interest on lease liabilities60 29 
Operating lease cost4,703 4,918 
Short-term lease cost356 227 
Variable lease cost733 616 
Total lease cost$6,507 $6,307 

17

Other Supplemental Information
Three Months Ended
April 2, 2023April 3, 2022
(in thousands)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from finance leases$52 $21 
Operating cash flows from operating leases4,201 4,635 
Financing cash flows from finance leases643 479 
Right-of-use assets obtained in exchange for new finance lease liabilities557 382 
Right-of-use assets obtained in exchange for new operating lease liabilities1,121 20 
Lease Term and Discount Rate
The table below presents the weighted average remaining lease terms and discount rates for finance and operating leases as of April 2, 2023 and January 1, 2023:
 April 2, 2023January 1, 2023
Weighted-average remaining lease term – finance leases (in years)3.733.82
Weighted-average remaining lease term – operating leases (in years)9.169.29
Weighted-average discount rate – finance leases4.16 %3.79 %
Weighted-average discount rate – operating leases5.91 %5.89 %
Maturity Analysis
A maturity analysis of lease payments under non-cancellable leases is presented as follows:
Fiscal YearOperating LeasesFinance Leases
(in thousands)
2023 (excluding the three months ended April 2, 2023)
$10,792 $1,761 
202414,237 2,069 
202512,463 1,260 
202612,407 711 
202710,015 495 
Thereafter49,813 496 
Total future minimum lease payments (undiscounted)109,727 6,792 
Less: Present value discount(26,801)(569)
Total lease liability$82,926 $6,223 

18

NOTE 9 – EMPLOYEE BENEFIT PLANS
During the three-month periods ended April 2, 2023 and April 3, 2022, the Company recorded multi-employer pension expense related to multi-employer contributions of $0.6 million and $0.7 million, respectively.
The following tables provide the components of net periodic benefit cost for the three months ended April 2, 2023 and April 3, 2022:
Three Months Ended
Defined Benefit Retirement Plans (Europe)
April 2, 2023April 3, 2022
(in thousands)
Interest cost$1,735 $916 
Expected return on plan assets(1,964)(1,059)
Amortization of prior service cost29 32 
Amortization of net actuarial losses223 275 
Net periodic benefit cost$23 $164 
Three Months Ended
Salary Continuation PlanApril 2, 2023April 3, 2022
(in thousands)
Interest cost$283 $193 
Amortization of net actuarial losses49 139 
Net periodic benefit cost$332 $332 
Three Months Ended
nora Defined Benefit Plan
April 2, 2023April 3, 2022
(in thousands)
Service cost$114 $225 
Interest cost272 110 
Amortization of net actuarial (gains) losses(109)50 
Net periodic benefit cost$277 $385 
In accordance with applicable accounting standards, the service cost component of net periodic benefit costs is presented within operating income in the consolidated condensed statements of operations, while all other components of net periodic benefit costs are presented within other expense, net, in the consolidated condensed statements of operations.
19

NOTE 10 – GOODWILL AND INTANGIBLE ASSETS
The ending balance and the change in the carrying amounts of goodwill for the three months ended April 2, 2023 are as follows:
Goodwill(1)
(in thousands)
Balance, at January 1, 2023$102,417 
Foreign currency translation(2)
1,257 
Balance, at April 2, 2023$103,674 
(1) The goodwill balance is allocated entirely to the AMS reportable segment. All goodwill allocated to the EAAA reportable segment was previously written off as a result of impairment charges.
(2) A portion of the goodwill balance is comprised of goodwill denominated in foreign currency attributable to the nora acquisition.
The net carrying value of intangible assets other than goodwill was $59.2 million and $59.8 million at April 2, 2023 and January 1, 2023, respectively.
20

NOTE 11 – SEGMENT INFORMATION
The Company determines that an operating segment exists if a component (i) engages in business activities from which it earns revenues and incurs expenses, (ii) has operating results that are regularly reviewed by the chief operating decision maker (“CODM”) and (iii) has discrete financial information. Additionally, accounting standards require the utilization of a “management approach” to report the financial results of operating segments, which is based on information used by the CODM to assess performance and make operating and resource allocation decisions. The Company determined that it has two operating segments organized by geographical area – namely (a) Americas (“AMS”) and (b) Europe, Africa, Asia and Australia (collectively “EAAA”). The AMS operating segment includes the United States, Canada and Latin America geographic areas.
Pursuant to the management approach discussed above, the Company’s CODM, our chief executive officer, evaluates performance at the AMS and EAAA operating segment levels and makes operating and resource allocation decisions based on segment adjusted operating income (“AOI”), which includes allocations of corporate selling, general and administrative expenses. AOI excludes nora purchase accounting amortization; Thailand plant closure inventory write-down; Cyber Event impact; property casualty loss; and restructuring, asset impairment, severance and other charges. Intersegment revenues for the three months ended April 2, 2023 and April 3, 2022 were $22.6 million and $17.3 million, respectively. Intersegment revenues are eliminated from net sales presented below since these amounts are not included in the information provided to the CODM.
The Company has determined that it has two reportable segments – AMS and EAAA, as each operating segment meets the quantitative thresholds defined in the accounting guidance.
Segment information for the three months ended April 2, 2023 and April 3, 2022 is presented in the following table:
Three Months Ended
April 2, 2023April 3, 2022
(in thousands)
Net sales
AMS$169,241 $156,509 
EAAA126,551 131,493 
Total net sales$295,792 $288,002 
 
Segment AOI
AMS$11,269 $21,138 
EAAA 3,929 9,504 
 
Depreciation and amortization
AMS$4,393 $4,058 
EAAA5,598 6,612 
Total depreciation and amortization$9,991 $10,670 
21

A reconciliation of the Company’s total operating segment assets to the corresponding consolidated amounts follows:
April 2, 2023January 1, 2023
(in thousands)
Assets
AMS$554,790 $588,110 
EAAA655,823 652,921 
Total segment assets1,210,613 1,241,031 
Corporate assets121,418 110,495 
Eliminations(78,826)(85,023)
Total reported assets$1,253,205 $1,266,503 
Reconciliations of operating income to income (loss) before income tax expense and segment AOI are presented as follows:
Three Months Ended
April 2, 2023April 3, 2022
(in thousands)
AMS operating income$8,715 $21,250 
EAAA operating income762 6,170 
Consolidated operating income9,477 27,420 
Interest expense8,505 6,850 
Other expense, net1,500 170 
Income (loss) before income tax expense$(528)$20,400 
Three Months Ended April 2, 2023Three Months Ended April 3, 2022
AMSEAAAAMSEAAA
(in thousands)
Operating income$8,715 $762 $21,250 $6,170 
Purchase accounting amortization— 1,283 — 1,342 
Thailand plant closure inventory write-down— — — 1,115 
Cyber Event impact228 200 — — 
Property casualty loss1,300 — — — 
Restructuring, asset impairment, severance and other charges1,026 1,684 (112)877 
AOI$11,269 $3,929 $21,138 $9,504 

22

NOTE 12 – SUPPLEMENTAL CASH FLOW INFORMATION
Cash payments for interest amounted to $3.7 million and $1.3 million for the three months ended April 2, 2023 and April 3, 2022, respectively. Income tax payments, net of refunds, amounted to $5.1 million and $2.8 million for the three months ended April 2, 2023 and April 3, 2022, respectively.
See Note 8 entitled “Leases” for supplemental disclosures related to finance and operating leases.
Non-Cash Financing Activities
On March 14, 2023, the Company declared cash dividends on its common stock of $0.6 million, which were paid during the second quarter of 2023 to shareholders of record as of March 31, 2023. At April 2, 2023, the dividends were recorded within accrued expenses in the consolidated condensed balance sheet.
23

NOTE 13 – INCOME TAXES
The Company determines its provision for income taxes for interim periods using an estimate of its annual effective tax rate (“AETR”) and records any changes affecting the estimated AETR in the interim period in which the change occurs, including discrete tax items.
During the three months ended April 2, 2023, the Company recorded a total income tax provision of $0.2 million on pre-tax loss of $0.5 million resulting in a negative effective tax rate of 35.2%, as compared to a total income tax provision of $7.1 million on pre-tax income of $20.4 million resulting in an effective tax rate of 34.8% during the three months ended April 3, 2022. The pre-tax loss for the three months ended April 2, 2023 included significant unusual or infrequent items that are specifically excluded from the AETR. The tax effects related to these specifically excluded items are recognized discretely. The income tax benefits recognized discretely were at a lower effective tax rate compared to the estimated AETR resulting in an overall negative effective tax rate for the three months ended April 2, 2023. The year-over-year change in the effective tax rate is primarily due to the tax effects of relatively low pre-tax loss in the current year quarter compared to pre-tax income in the prior year quarter and favorable changes related to the cash surrender value of Company-owned life insurance policies.
In the first three months of 2023, the Company increased its liability for unrecognized tax benefits by $0.3 million. As of April 2, 2023, the Company had accrued approximately $6.0 million for unrecognized tax benefits. In accordance with applicable accounting standards, the Company’s deferred tax asset as of April 2, 2023 reflects a reduction for $2.8 million of these unrecognized tax benefits.
Unrecognized tax benefits are reviewed on an ongoing basis and are adjusted for changing facts and circumstances, including the progress of tax audits and the closing of statutes of limitations. Based on information currently available, it is reasonably possible that approximately $1.1 million of unrecognized tax benefits may be recognized within the next 12 months, of which $0.4 million would result in a favorable impact to the effective tax rate.
24

NOTE 14 – ITEMS RECLASSIFIED FROM ACCUMULATED OTHER COMPREHENSIVE LOSS
Amounts reclassified out of accumulated other comprehensive loss (“AOCI”), before tax, to the consolidated condensed statements of operations during the three months ended April 2, 2023 and April 3, 2022 are reflected in the table below:
Three Months Ended
Statement of Operations LocationApril 2, 2023April 3, 2022
(in thousands)
Interest rate swap contracts lossInterest expense$(393)$(893)
Amortization of benefit plan net actuarial losses and prior service costOther expense, net(192)(496)
Total loss reclassified from AOCI$(585)$(1,389)


25

NOTE 15 – RESTRUCTURING AND OTHER CHARGES
Restructuring, asset impairment and other charges are as follows:
Three Months Ended
April 2, 2023April 3, 2022
(in thousands)
Restructuring, asset impairment and other charges(1)
$142 $887 
(1) Charges are attributable to the EAAA reportable segment.
2021 Restructuring Plan
A summary of the restructuring reserve balance, recorded within accrued expenses in the consolidated condensed balance sheets, for the 2021 restructuring plan is presented below:
Workforce ReductionRetention BonusesAsset Impairment and Other Related ChargesTotal
(in thousands)
Balance, at January 1, 2023$277 $179 $— $456 
Charged to expenses23 (19)138 142 
Deductions(300)(160)— (460)
Charged to other accounts— — (138)(138)
Balance, at April 2, 2023$— $— $— $— 
Below is a discussion of the restructuring plan activities under the 2021 restructuring plan.
On September 8, 2021, the Company committed to a new restructuring plan that continued to focus on efforts to improve efficiencies and decrease costs across its worldwide operations. The plan involved a reduction of approximately 188 employees and the closure of the Company’s manufacturing facility in Thailand at the end of the first quarter of 2022.
Expected charges and cumulative charges incurred to date under the 2021 restructuring plan are as follows:
Workforce ReductionRetention BonusesAsset Impairment and Other Related ChargesTotal
(in thousands)
Estimated expected charges(1)
$2,281 $474 $3,259 $6,014 
Cumulative charges incurred to date(1)
2,281 474 3,259 6,014 
(1) Charges are attributable to the EAAA reportable segment.
In addition, during the three months ended April 3, 2022, in conjunction with the closure of its Thailand facility, the Company recorded a write-down of inventory of $1.1 million within cost of sales in the consolidated condensed statements of operations.
The restructuring plan was expected to result in cash expenditures of approximately $3 million to $4 million for payment of employee severance, employee retention bonuses and other costs to shut down the Thailand manufacturing facility, as described above. The Company expects to complete the restructuring plan in the second quarter of 2023 following the sale of the Thailand manufacturing facility, as described in Note 16 entitled “Assets Held For Sale,” and expects the plan to yield annualized savings of approximately $1.7 million. A portion of the annualized savings was realized on the consolidated condensed statements of operations in fiscal year 2022, with the remaining portion of the annualized savings expected to be realized in fiscal year 2023.
26

NOTE 16 – ASSETS HELD FOR SALE
On September 8, 2021, the Company announced a restructuring plan that involved the closure of its manufacturing facility in Thailand and committed to a plan to sell the Thailand facility in connection with this restructuring plan. See Note 15 entitled “Restructuring and Other Charges” for additional information. On March 7, 2023, the Company entered into a binding agreement to sell the Thailand manufacturing facility for approximately $6.7 million. The transaction is expected to close in the second quarter of 2023.
The Company determined that the Thailand manufacturing facility met the assets held for sale criteria during the first quarter of 2023. Accordingly, we have reported the carrying value of the manufacturing facility as assets held for sale in the consolidated condensed balance sheet as of April 2, 2023. We discontinued recording depreciation expense on the manufacturing facility once the assets held for sale criteria were met. We determined that the Thailand facility sale did not meet the criteria for classification as discontinued operations.



27

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Our discussions below in this Item 2 are based upon the more detailed discussions about our business, operations and financial condition included in our Annual Report on Form 10-K for the fiscal year ended January 1, 2023, under Part II, Item 7 of that Form 10-K. Our discussions here focus on our results during the quarter ended April 2, 2023, or as of, April 2, 2023, and the comparable periods of 2022, and to the extent applicable, any material changes from the information discussed in that Form 10-K or other important intervening developments or information since that time. These discussions should be read in conjunction with that Form 10-K for more detailed and background information. The three-month periods ended April 2, 2023 and April 3, 2022 both include 13 weeks.
Forward-Looking Statements
This report contains statements which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include risks and uncertainties associated with the economic conditions in the commercial interiors industry as well as the risks and uncertainties discussed under the heading “Risk Factors” included in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2023. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time.
28

Table of Contents
Overview
During the quarter ended April 2, 2023, we had consolidated net sales of $295.8 million, up 2.7% compared to $288.0 million in the first quarter last year. Higher sales were primarily in the education, corporate office, public buildings and residential market segments. Consolidated operating income was $9.5 million for the first quarter of 2023, compared to $27.4 million in the first quarter last year. Continuing inflationary pressures on raw materials and lower manufacturing fixed cost absorption on lower manufacturing volumes adversely impacted our gross profit margin in the current year period coupled with higher selling, general and administrative costs. Consolidated net loss for the quarter ended April 2, 2023 was $0.7 million or $0.01 per share, compared to consolidated net income of $13.3 million or $0.22 per share in the first quarter last year.
Cybersecurity Event
As previously disclosed in our current report on Form 8-K filed with the SEC on November 23, 2022, we discovered a cybersecurity attack, perpetrated by unauthorized third parties, affecting our IT systems on November 20, 2022 (the “Cyber Event”). Promptly, out of an abundance of caution, we shut down certain systems including shipping, inventory management and production systems and engaged forensic experts to evaluate the extent of the Cyber Event and its impact to our operations. We took steps to supplement existing security monitoring, including scanning and protective measures, and notified law enforcement. We substantially resumed our operations within two weeks following the occurrence of the Cyber Event.

In the first quarter of 2023, we incurred approximately $0.4 million of additional expenses related to the ongoing investigation of the Cyber Event. These costs were primarily included in selling, general and administrative expenses in the consolidated condensed statement of operations. We have cyber risk insurance and anticipate that a portion of our costs and expenses related to the Cyber Event will ultimately be recovered by insurance. We expect to incur ongoing costs for enhanced data security against unauthorized access to, or manipulation of, our systems and data.
Impact of Macroeconomic Trends
The continued disruption in economic markets due to high inflation, increases in interest rates, supply chain issues, and the continuing impact of COVID-19 in China all pose challenges which may adversely affect our future performance. These impacts have increased our costs and adversely affected our gross profit margin. To mitigate these impacts, we plan to continue evaluating our cost structure and global manufacturing footprint to identify and activate opportunities to decrease costs and optimize our global cost structure.
During the first quarter of 2023, EAAA sales were also adversely impacted by slower economic recovery and decreased customer demand in parts of Asia, resulting in approximately 30% lower net sales in Asia during the current quarter compared to the same period last year.


29

Table of Contents
Analysis of Results of Operations
Consolidated Results
The following table presents, as a percentage of net sales, certain items included in our consolidated condensed statements of operations for the three-month periods ended April 2, 2023 and April 3, 2022:
Three Months Ended
April 2, 2023April 3, 2022
Net sales100.0 %100.0 %
Cost of sales67.6 62.9 
Gross profit32.4 37.1 
Selling, general and administrative expenses29.2 27.3 
Restructuring, asset impairment and other charges0.0 0.3 
Operating income3.2 9.5 
Interest/Other expense, net3.4 2.4 
Income (loss) before income tax expense(0.2)7.1 
Income tax expense0.1 2.5 
Net income (loss)(0.3)%4.6 %
Consolidated Net Sales
Below is information regarding our consolidated net sales, and analysis of those results, for the three-month periods ended April 2, 2023, and April 3, 2022:
Three Months EndedPercentage
Change
April 2, 2023April 3, 2022
(in thousands)
Consolidated net sales$295,792 $288,002 2.7 %
For the quarter ended April 2, 2023, consolidated net sales increased $7.8 million (2.7%) versus the comparable period in 2022, primarily due to higher prices (approximately 6%). Currency fluctuations had a negative impact on consolidated net sales of approximately $7.2 million (2.5%) for the first quarter of 2023, due primarily to the weakening of the Euro, Australian dollar and British Pound sterling against the U.S. dollar. On a market segment basis, the sales increase was primarily in the education, corporate office, public buildings and residential living market segments as a result of higher government spending on school renovation projects and corporate reinvestment.
Consolidated Cost and Expenses
The following table presents our consolidated cost of sales and selling, general and administrative expenses for the three-month periods ended April 2, 2023, and April 3, 2022:
Three Months EndedPercentage
Change
April 2, 2023April 3, 2022
(in thousands)
Cost of sales$199,919 $181,203 10.3 %
Selling, general and administrative expenses86,254 78,492 9.9 %
Consolidated Cost of Sales
For the quarter ended April 2, 2023, consolidated cost of sales increased $18.7 million (10.3%) compared to the first quarter of 2022, primarily due to continuing inflationary pressures on raw material costs. Currency translation had a positive impact on consolidated cost of sales in the first quarter of 2023 and partially reduced our costs by approximately $5.1 million (3.0%) compared to the same period last year. As a percentage of net sales, our cost of sales increased to 67.6% for the first quarter of 2023 versus 62.9% for the first quarter of 2022.
30

Table of Contents
Consolidated Gross Profit
For the quarter ended April 2, 2023, consolidated gross profit, as a percentage of net sales, was 32.4% compared with 37.1% in the same period last year. The decrease was primarily due to continuing inflationary pressures on raw material costs and lower manufacturing fixed cost absorption on lower manufacturing volumes as discussed above.
Consolidated Selling, General and Administrative (“SG&A”) Expenses
For the quarter ended April 2, 2023, consolidated selling, general and administrative expenses increased $7.8 million (9.9%) versus the comparable period in 2022. Currency translation had a positive impact on consolidated SG&A expenses in the first quarter of 2023 and partially reduced our costs by approximately $1.3 million (1.5%) compared to the same period last year. SG&A expenses were higher for the first quarter of 2023 primarily due to higher selling expenses of approximately $3.7 million due to higher sales, higher severance costs of approximately $2.3 million driven by employee headcount reduction and cost saving initiatives, Cyber Event costs of approximately $0.5 million and the continuing impact of inflation. As a percentage of net sales, SG&A expenses increased to 29.2% for the first quarter of 2023 versus 27.3% for the first quarter of 2022. 
Restructuring Activities
On September 8, 2021, the Company committed to a new restructuring plan that continued to focus on efforts to improve efficiencies and decrease costs across its worldwide operations, involving the closure of the Company’s manufacturing facility in Thailand at the end of the first quarter of 2022. In the first quarter of 2023, we recognized restructuring charges of approximately $0.1 million under this plan primarily related to the transfer of equipment from the Thailand facility to other manufacturing locations.
See Note 15 entitled “Restructuring and Other Charges” and Note 16 entitled “Assets Held For Sale” of Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.
Interest Expense
During the quarter ended April 2, 2023, interest expense was $8.5 million, an increase of $1.7 million from the comparable period in 2022, primarily due to higher interest rates on outstanding term loan borrowings under the Facility.


31

Table of Contents
Segment Operating Results
AMS Segment Net Sales and Adjusted Operating Income (“AOI”)
The following table presents AMS segment net sales and AOI for the three-month periods ended April 2, 2023, and April 3, 2022:
Three Months EndedPercentage Change
April 2, 2023April 3, 2022
(in thousands)
AMS segment net sales$169,241 $156,509 8.1 %
AMS segment AOI(1)
11,269 21,138 (46.7)%
(1) Includes allocation of corporate SG&A expenses. Excludes Cyber Event costs, property casualty loss, and restructuring, asset impairment, severance and other costs. See Note 11 entitled “Segment Information” of Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.
During the first quarter of 2023, net sales in AMS increased 8.1% versus the comparable period in 2022 primarily due to higher sales prices and volume. The AMS sales increase was primarily in the corporate office, education and residential living market segments.
AOI in AMS decreased 46.7% during the first quarter of 2023 compared to the prior year period primarily due to higher raw material costs as a result of continuing inflationary pressures. Unfavorable fixed cost absorption in the current period also negatively impacted AOI. AMS SG&A expenses as a percentage of net sales in the first quarter of 2023 increased 1.0% due to higher selling expenses and inflation, which also contributed to the decrease in AOI for the current quarter. As a percentage of net sales, AOI decreased to 6.7% during the first quarter of 2023 compared to 13.5% in the same period last year.
EAAA Segment Net Sales and AOI
The following table presents EAAA segment net sales and AOI for the three-month periods ended April 2, 2023, and April 3, 2022:
Three Months EndedPercentage Change
April 2, 2023April 3, 2022
(in thousands)
EAAA segment net sales$126,551 $131,493 (3.8)%
EAAA segment AOI(1)
3,929 9,504 (58.7)%
(1) Includes allocation of corporate SG&A expenses. Excludes purchase accounting amortization, Cyber Event costs, Thailand plant closure inventory write-down, and restructuring, asset impairment, severance and other costs. See Note 11 entitled “Segment Information” of Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.
During the first quarter of 2023, net sales in EAAA decreased 3.8% versus the comparable period in 2022, as higher sales prices were offset by the negative impacts of currency fluctuations and lower sales volume in Asia. Currency fluctuations had a negative impact on EAAA sales of approximately $6.3 million (4.8%) for the first quarter 2023 compared to the same period last year due to the weakening of the Euro, Australian dollar and British Pound sterling against the U.S. dollar. During the first quarter of 2023, EAAA sales were also adversely impacted by slower economic recovery and decreased customer demand in parts of Asia. On a market segment basis, the EAAA sales decrease was most significant in the corporate office, healthcare and retail market segments, partially offset by increases in the public buildings and education market segments.
AOI in EAAA decreased 58.7% during the first quarter of 2023 versus the comparable period in 2022, primarily due to higher raw material costs as a result of continuing inflationary pressures and lower manufacturing fixed cost absorption on lower manufacturing production volumes. Currency fluctuations had a negative impact on AOI of approximately $0.7 million (4.4%) for the first quarter of 2023 compared to the first quarter last year. EAAA SG&A expenses as a percentage of net sales in the first quarter of 2023 decreased approximately 0.6% compared to the first quarter of 2022, which partially offset the decrease in AOI for the first quarter of 2023. As a percentage of net sales, AOI decreased to 3.1% during the first quarter of 2023 compared to 7.2% in the same period last year.
32

Table of Contents
Financial Condition, Liquidity and Capital Resources
General
At April 2, 2023, the Company had $101.3 million in cash. At that date, the Company had $197.6 million in term loan borrowings, $9.4 million in revolving loan borrowings, and $1.6 million in letters of credit outstanding under our Facility, and we had $300.0 million of Senior Notes outstanding. As of April 2, 2023, we had additional borrowing capacity of $289.0 million under the Facility. We anticipate that our liquidity is sufficient to meet our obligations for the next 12 months, and we expect to generate sufficient cash to meet our long-term obligations.
The Senior Notes are unsecured and are guaranteed, jointly and severally, by each of the Company’s material domestic subsidiaries, all of which also guarantee the obligations of the Company under its Facility. The Company’s foreign subsidiaries and certain non-material domestic subsidiaries are considered non-guarantors. Net sales for the non-guarantor subsidiaries were approximately $141 million and $144 million for the three-month periods ended April 2, 2023 and April 3, 2022, respectively. Total indebtedness of the non-guarantor subsidiaries was approximately $41 million and $43 million as of April 2, 2023 and January 1, 2023, respectively.
Balance Sheet
Accounts receivable, net, were $147.8 million at April 2, 2023, compared to $182.8 million at January 1, 2023. The decrease of $35.0 million was primarily due to customer collections in the first quarter of 2023, including the impact of delays in customer billings from the Cyber Event, in which the due dates for those delayed billings were pushed from the fourth quarter of 2022 to the first quarter of 2023.
Inventories, net, were $312.7 million at April 2, 2023, compared to $306.3 million at January 1, 2023. The increase of $6.4 million was primarily due to higher raw material costs due to continuing inflationary pressures.
Analysis of Cash Flows
The following table presents a summary of cash flows for the three-month periods ended April 2, 2023 and April 3, 2022, respectively:
Three Months Ended
April 2, 2023April 3, 2022
(in thousands)
Net cash provided by (used in):
Operating activities$29,584 $(17,696)
Investing activities(5,712)(4,781)
Financing activities(21,035)2,894 
Effect of exchange rate changes on cash872 (1,581)
Net change in cash and cash equivalents3,709 (21,164)
Cash and cash equivalents at beginning of period97,564 97,252 
Cash and cash equivalents at end of period$101,273 $76,088 
Cash provided by operating activities was $29.6 million for the three months ended April 2, 2023, compared with $17.7 million of cash used in operating activities in the prior year comparable period. The increase was primarily due to a greater source of cash from working capital during the first three months of 2023. Specifically, customer collections in the first three months of 2023 contributed to a decrease in accounts receivable, primarily attributable to delays in customer billings from the Cyber Event, in which the due dates for those delayed billings were pushed from the fourth quarter of 2022 to the first quarter of 2023. The prior year comparable period included a greater use of cash for working capital attributable to an increase in inventories compared with the three months ended April 2, 2023.
Cash used in investing activities was $5.7 million for the three months ended April 2, 2023, which represents an increase of $0.9 million from the prior year comparable period. The increase from the comparable period was primarily due to an increase in capital expenditures due to higher capital investment.

33

Table of Contents
Cash used in financing activities was $21.0 million for the three months ended April 2, 2023, compared with $2.9 million of cash provided by financing activities in the prior year comparable period. The increased use of cash was primarily due to higher repayments of revolving loan borrowings in 2023 as a result of cash generated from operating activities as described above.
Outlook

We anticipate revenue growth in the second quarter of fiscal year 2023 compared with the first quarter of 2023. We are also anticipating continued impacts to our global supply chain and manufacturing operationsparticularly significant cost increases in our raw materials globally and continued lower manufacturing fixed cost absorption versus the comparable prior year period. The impacts may also potentially include shipping delays, and other disruption. These impacts to our supply chain and manufacturing operations may increase our costs and continue to adversely affect our gross margins, they may inhibit our ability to manufacture and ship product timely, and at times they may inhibit our ability to meet customer demands and expectations.
Cash flows from operations, cash and cash equivalents, and other sources of liquidity are expected to be available and sufficient to meet foreseeable cash requirements. However, the Company’s cash flows from operations can be affected by numerous factors including raw material availability and cost, and demand for our products.
Backlog
As of April 23, 2023, the consolidated backlog of unshipped orders was approximately $208.9 million. As disclosed in our Annual Report on Form 10-K for the fiscal year ended January 1, 2023, backlog was approximately $197.4 million as of February 5, 2023. Disruptions in supply and distribution chains and the impact of government imposed COVID-19 lockdowns in China have resulted in delays of construction projects and flooring installations in many regions worldwide.
34

Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The discussion below in this Item 3 is based upon the more detailed discussions of our market risk and related matters included in our Annual Report on Form 10-K for the fiscal year ended January 1, 2023, under Part II, Item 7A of that Form 10-K. The discussion here focuses on the three months ended April 2, 2023, and any material changes from (or other important intervening developments since the time of) the information discussed in that Form 10-K. This discussion should be read in conjunction with that Form 10-K for more detailed and background information.
Sensitivity Analysis
For purposes of specific risk analysis, we use sensitivity analysis to measure the impact that market risk may have on the fair values of our market sensitive instruments. To perform sensitivity analysis, we assess the risk of loss in fair values associated with the impact of hypothetical changes in interest rates and foreign currency exchange rates on market sensitive instruments.
Because the debt outstanding under our Facility has variable interest rates based on an underlying prime lending rate or other benchmark rate, we do not believe changes in interest rates would have any significant impact on the fair value of that debt instrument. Changes in the underlying prime lending rate or other benchmark rate would, however, impact the amount of our interest expense. For a discussion of these hypothetical impacts on our interest expense, please see the discussion in Part II, Item 7A of our Annual Report on Form 10-K for the year ended January 1, 2023.
As of April 2, 2023, based on a hypothetical immediate 100 basis point increase in interest rates, with all other variables held constant, the fair value of our fixed rate long-term debt would be impacted by a net decrease of $11.0 million. Conversely, a 100 basis point decrease in interest rates would result in a net increase in the fair value of our fixed rate long-term debt of $11.6 million.
As of April 2, 2023, a 10% decrease or increase in the levels of foreign currency exchange rates against the U.S. dollar, with all other variables held constant, would result in a decrease in the fair value of our financial instruments of $9.6 million or an increase in the fair value of our financial instruments of $11.7 million, respectively. As the impact of offsetting changes in the fair market value of our net foreign investments is not included in the sensitivity model, these results are not indicative of our actual exposure to foreign currency exchange risk.

35

Table of Contents
ITEM 4. CONTROLS AND PROCEDURES
As of the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was performed under the supervision and with the participation of our management, including our President and Chief Executive Officer and our Vice President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Act”), pursuant to Rule 13a-14(c) under the Act.
No system of controls, no matter how well designed and operated, can provide absolute assurance that the objectives of the system of controls are met, and no evaluation of controls can provide absolute assurance that the system of controls has operated effectively in all cases. Our disclosure controls and procedures however are designed to provide reasonable assurance that the objectives of disclosure controls and procedures are met.
Based on the evaluation, our President and Chief Executive Officer and our Vice President and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report to provide reasonable assurance that the objectives of disclosure controls and procedures are met.
There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
36

Table of Contents
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
From time to time, we are a party to legal proceedings, whether arising in the ordinary course of business or otherwise. The disclosure under the headings “Lawsuit by Former CEO in Connection with Termination” and “Putative Class Action Lawsuit” set forth in Note 18 to the consolidated financial statements included in Item 8 of the Annual Report on Form 10-K for the fiscal year ended January 1, 2023 is incorporated by reference herein.
In the lawsuit by the former CEO, Mr. Gould has filed a motion for reconsideration of the Court’s grant of summary judgment in favor of the Company on Mr. Gould’s breach of contract claim. That motion for reconsideration is currently pending with the Court. In addition, the Court has scheduled a trial on the Company’s counterclaim against Mr. Gould for breach of fiduciary duty beginning September 12, 2023. The Company believes Mr. Gould’s lawsuit is without merit and intends to defend vigorously against it.
In the putative class action, the parties have reached a preliminary agreement to settle the lawsuit for $7.5 million, subject to Court approval of the settlement. The Company expects the settlement amount to be paid by its insurers. The Company has accrued both the $7.5 million loss contingency as well as the expected insurance recovery in the consolidated condensed balance sheet as of April 2, 2023.
ITEM 1A. RISK FACTORS
In addition to the other information set forth in this report, you should carefully consider the risk factors disclosed in Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended January 1, 2023.

37

Table of Contents
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following table contains information with respect to purchases made by or on behalf of the Company, or any “affiliated purchaser” (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934), of our common stock during our first quarter ended April 2, 2023:
Period(1)
Total
Number of
Shares
Purchased
Average
Price
Paid
Per Share
Total Number
of Shares Purchased
as Part of Publicly Announced Plans or Programs(2)
Approximate Dollar Value of Shares that
May Yet Be
Purchased Under the
Plans or Programs(2)
January 2 – January 29, 2023— $— — $82,828,595 
January 30 – February 26, 2023(3)
30,006 11.58 — 82,858,595 
February 27 – April 2, 2023(3)
95,864 8.55 — 82,828,595 
Total125,870 $9.27 — 
(1) The monthly periods identified above correspond to the Company’s fiscal first quarter of 2023, which commenced January 2, 2023 and ended April 2, 2023.
(2) On May 17, 2022, the Company announced a share repurchase program authorizing the repurchase of up to $100 million of common stock. The program has no specific expiration date.
(3) Comprised of shares acquired by the Company from employees to satisfy income tax withholding obligations in connection with the vesting of previous equity awards.

38

Table of Contents
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None

ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.

ITEM 5. OTHER INFORMATION
None
39

Table of Contents
ITEM 6. EXHIBITS
The following exhibits are filed or furnished with this report:
Exhibit NumberDescription of Exhibit
10.1
10.2
31.1
31.2
32.1
32.2
101.INSXBRL Instance Document – The Instance Document does not appear in the Interactive Data Files because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document.
101.CALXBRL Taxonomy Extension Calculation Linkbase Document.
101.LABXBRL Taxonomy Extension Label Linkbase Document.
101.PREXBRL Taxonomy Presentation Linkbase Document.
101.DEFXBRL Taxonomy Definition Linkbase Document.
104
The cover page from this Quarterly Report on Form 10-Q for the quarter ended April 2, 2023, formatted in Inline XBRL
* Management contract or compensatory plan or agreement
40

Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
INTERFACE, INC.
Date: May 9, 2023By:/s/  Bruce A. Hausmann
Bruce A. Hausmann
Chief Financial Officer
(Principal Financial Officer)
41

INTERFACE, INC.
RESTRICTED SHARE UNIT AGREEMENT
This Restricted Share Unit Agreement (this “Agreement”) is entered into as of the ____ day of ________, 202_, by and between Interface, Inc. (the “Company”) and _______________________ (“Grantee”).
W I T N E S S E T H:
WHEREAS, the Company has adopted the Interface, Inc. 2020 Omnibus Stock Incentive Plan (the “Plan”) which is administered by a committee appointed by the Company’s Board of Directors (the “Committee”); and
WHEREAS, the Committee has granted to Grantee an award of Restricted Share Units under the terms of the Plan (the “Award”) to encourage Grantee’s continued loyalty and diligence; and
WHEREAS, to comply with the terms of the Plan and to further the interests of the Company and Grantee, the parties hereto have set forth the terms of the Award in writing in this Agreement.
NOW, THEREFORE, for and in consideration of the mutual promises herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
1.    Plan Provisions.
In addition to the terms and conditions set forth herein, the Award is subject to and governed by the terms and conditions set forth in the Plan, which are hereby incorporated herein by reference. Any terms used herein with an initial capital letter shall have the same meaning as provided in the Plan, unless otherwise specified herein. In the event of any conflict between the provisions of this Agreement and the Plan, the Plan shall control.
2.    Award.
(a)    Effective on ________ __, 202_ (the “Grant Date”), and subject to the restrictions and other conditions set forth herein, the Committee granted to Grantee an Award of ____________________ restricted share units representing shares of common stock, $.10 par value per share, of the Company (“Shares”). Such restricted share units granted are hereinafter sometimes referred to as the “Restricted Share Units.” The Fair Market Value of each Restricted Share Unit awarded on the Grant Date was $_____. The Restricted Share Units are granted pursuant to Section 8 of the Plan, which authorizes the grant of Shares to be issued on a deferred basis in consideration of future services.
(b)    If cash dividends are paid with respect to Shares, Grantee shall be credited with a “dividend equivalent” representing the right to receive a cash payment equal to the amount of such dividend with respect of each Restricted Share Unit remaining subject to the Award. If dividends are paid in the form of Shares rather than cash, then the number of Restricted Share Units subject to the Award shall be increased by the number of Shares that would have been received as a dividend had such Restricted Share Unit been outstanding Shares. Dividend equivalents and additional Restricted Share Units credited under this Section with respect to dividends paid in a calendar year shall vest or be forfeited on the same terms, and shall



be payable as soon as reasonably practicable after Shares are distributed to Grantee in respect of the related Restricted Share Units.
3.    Vesting Restrictions.
(a)    General. All or a portion (as applicable) of the Restricted Share Units will vest and no longer be subject to forfeiture if one of several criteria is satisfied. As described below, these criteria are based on Grantee’s tenure of employment, the termination of Grantee’s employment after occurrence of a Change in Control (as defined in subsection (c) hereof), and/or certain other events resulting in termination of Grantee’s employment with the Company.
(b)    Tenure of Employment. The Restricted Share Units shall vest over a three-year period with one-third of the Restricted Share Units vesting on each of the first, second, and third anniversaries of the Grant Date, in each case provided that Grantee remains continuously employed by the Company or any of its Subsidiaries from the Grant Date until such anniversary date.
(c)    Termination After a Change in Control. If within 24 months following the occurrence of a Change in Control (as defined below) Grantee’s employment with the Company and its Subsidiaries terminates as a result of (i) involuntary termination at the request of the Company (or the Subsidiary that is Grantee’s employer) for any reason other than Cause (as defined in Section 4 below), or (ii) a voluntary termination by Grantee with Good Reason (as defined below), any Restricted Share Units granted hereunder that have not yet vested or been forfeited will become fully vested on the date of Grantee’s termination of employment. For purposes hereof, “Change in Control” shall mean the earliest to occur of:
(i)    the acquisition by any “person”, entity, or “group” of “beneficial ownership” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, and rules promulgated thereunder) of more than 30 percent of the outstanding capital stock entitled to vote for the election of directors (“Voting Stock”) of (A) the Company, or (B) any corporation which is the surviving or resulting corporation, or the transferee corporation, in a transaction described in clause (ii)(A) or (ii)(B) immediately below;
(ii)    the effective time of (A) a merger, consolidation or other business combination of the Company with one or more corporations as a result of which the holders of the outstanding Voting Stock of the Company immediately prior to such merger or consolidation hold less than 51 percent of the Voting Stock of the surviving or resulting corporation, or (B) a transfer of all or substantially all of the property or assets of the Company other than to an entity of which the Company owns at least 51 percent of the Voting Stock, or (C) a plan of complete liquidation of the Company; and
(iii)    the election to the Board of Directors of the Company, without the recommendation or approval of the incumbent Board of Directors of the Company, of the lesser of (A) four directors, or (B) directors constituting a majority of the number of directors of the Company then in office.
“Good Reason” shall mean, following a Change in Control, (i) a material reduction in Grantee’s authorities, duties or responsibilities, (ii) a material reduction in Grantee’s base compensation or bonus opportunity as in effect immediately prior to the Change in Control, (iii) a material reduction in Grantee’s benefits, other than a reduction affecting substantially all similarly situated employees, (iv) a material reduction in any budget over which the Grantee has authority, or (v) a Company-required relocation of more than 30 miles of the Grantee’s principal place of employment. An event described in clause (i), (ii) or (iii) shall constitute Good Reason only if
2


the Grantee notifies the Company within 20 days of the occurrence of the event and the Company fails to take appropriate action to cure such event within 20 days after receiving such notice.
(d)    Retirement, Disability, Death, or Involuntary Termination without Cause. Upon the date that Grantee’s employment with the Company and its Subsidiaries terminates as a result of (i) Grantee’s Retirement (as such term is defined below), (ii) Grantee’s Disability (as defined below), (iii) Grantee’s death, or (iv) Grantee’s involuntary termination at the request of the Company (or the Subsidiary that is Grantee’s employer) for any reason other than Cause (as defined in Section 4 below), and the provisions of Section 3(c) above do not apply, all or a portion of the Restricted Share Units that have not yet vested or been forfeited will do so on such date, and Grantee thereupon will become vested in such Restricted Share Units; provided, however, that in the event of Grantee’s involuntary termination for any reason other than Cause, in order to vest in such Restricted Share Units Grantee must sign and not revoke a release of claims and acknowledgment in the form required by the Company. The number of Restricted Share Units that shall vest will be equal to the number of Restricted Share Units that would have vested had Grantee continued employment through the next anniversary of the Grant Date following the date of Grantee’s termination of employment. Any Restricted Share Units that do not vest as described herein shall be immediately forfeited, and Grantee (or Grantee’s heirs) shall not have any rights in such Restricted Share Units. For purposes hereof, the term “Retirement” shall mean Grantee’s termination of employment with the Company and its Subsidiaries for any reason, other than termination by the Company for Cause, after (i) Grantee has attained age 58, and (ii) the total of Grantee’s age and completed years of service with the Company and its subsidiaries equals at least 75. Age and years of service will be in whole years calculated as of the separation date, and years of service will be based on Grantee’s “Years of Vesting Service” determined under the Interface, Inc. Savings and Investment Plan. Notwithstanding the foregoing, Grantee will be considered to have terminated due to Retirement only if Grantee (i) has not already been notified by the Company that Grantee’s employment is being involuntarily terminated within the next six (6) months and, (ii) provides at least 90 days of advance written notice to the Company, unless a shorter period of notice is accepted by the Committee. For purposes hereof, the term “Disability” shall mean Grantee’s inability, as a result of physical or mental incapacity, to substantially perform Grantee’s duties for the Company and its Subsidiaries on a full-time basis for a continuous period of six months. The Committee, in its sole discretion, shall make all determinations as to whether or not Grantee has incurred a Disability, and the Committee’s determination shall be final and binding.
4.    Forfeiture Upon Resignation or Termination for Cause.
If Grantee voluntarily resigns from employment with the Company and all of its Subsidiaries prior to Retirement, or if the Company or the Subsidiary that is Grantee’s employer terminates Grantee’s employment for Cause (as defined below), any Restricted Share Units that are not then vested under any provision of Section 3 shall be immediately forfeited, and Grantee shall have no rights in such Restricted Share Units. For purposes hereof, the term “Cause” shall mean the reason for termination of Grantee’s employment is (A) Grantee’s fraud, dishonesty, gross negligence or willful misconduct, with respect to business affairs of the Company or its Subsidiaries, (B) Grantee’s refusal or repeated failure to follow the established lawful policies of the Company or its Subsidiaries applicable to persons occupying the same or similar positions, or (C) Grantee’s conviction of a felony or other crime involving moral turpitude.
5.    Limitations on Post-Termination Activities.
During the term of Grantee’s employment by the Company or any of its direct or indirect subsidiaries (collectively, the “Company Group”), and for a period of 12 months thereafter, Grantee will not (i) provide any “Services” within the geographic territory of the
3


business unit with whom Grantee is employed at the time of termination (whether Americas, EMEA or Asia-Pacific, as applicable, or, for corporate employees, all such geographic regions) to any person or entity (other than the Company Group) developing, manufacturing, marketing, selling, distributing (including, without limitation, through catalogs and similar instruments), installing, maintaining or reclaiming any carpet tile (also known as modular carpeting), broadloom carpet (whether 12-foot, six-foot or other competitive widths), luxury vinyl tile, rubber flooring, or other flooring for contract, commercial, institutional (including, without limitation, government and education), healthcare, transportation, life sciences, retail, hospitality or residential markets and customers, (ii) solicit, initiate contact with, call upon, initiate communication with or attempt to initiate communication with, directly or indirectly, any customer of the Company Group with whom Grantee had material contact within the most recent two years of Grantee’s employment, or any representative of any such customer, with a view to providing Services to such customers, or (iii) solicit or attempt to solicit, directly or indirectly, for employment with another person or entity a Company Group employee with whom Grantee had material contact during the most recent two years of Grantee’s employment. As used herein, “Services” shall mean the services which are the same as or substantially similar to the services Grantee provides to any Company Group entity within the most recent two years of Grantee’s employment, and that Grantee shall be prohibited from providing (whether as an owner, partner, employee, consultant or in any other capacity) in competition with any Company Group entity, in accordance with the terms of this paragraph, which include but are not limited to conducting the business of developing, manufacturing, marketing, selling, distributing, installing, maintaining or reclaiming any carpet tile, broadloom carpet, luxury vinyl tile, rubber flooring, or other flooring. During the term of Grantee’s employment by the Company Group, and for a period of 12 months thereafter, Grantee shall, before accepting employment with another employer, provide such prospective employer with a copy of this Section 5 of this Agreement and, upon accepting any employment with another employer, provide the Company with such employer’s name and a description of the services Grantee will provide to such employer. Upon any termination of Grantee’s employment for any reason whatsoever (whether voluntary on the part of Grantee, for just cause, without just cause, or for other reasons), the obligations of Grantee pursuant to this Section 5 shall survive and remain in effect.
The parties acknowledge and agree that (i) the covenants contained in this Section 5 are reasonable and necessary for the protection of the business and goodwill of the Company Group, (ii) any breach of the covenants in this Section 5 by Grantee will cause the Company Group substantial and irreparable harm, and (iii) Grantee has received good, valuable and adequate consideration in exchange for the covenants contained in this Section 5. Consequently, if the Grantee breaches any of the terms of this Section 5, the Grantee will forfeit the award described in this Agreement and all rights hereunder. The Company Group shall also be entitled to seek, in addition to other available remedies, a temporary or permanent injunction or other equitable relief against such breach or threatened breach from any court of competent jurisdiction, without the necessity of showing any actual damages or that money damages would not afford an adequate remedy, and without the necessity of posting any bond or other security. Such equitable relief will be in addition to, not in lieu of, legal remedies, monetary damages or other available forms of relief.
The covenants contained in this Section 5 shall be presumed to be enforceable, and any reading causing unenforceability shall yield to a construction permitting enforcement. If any single covenant or clause shall be found unreasonable, unenforceable or both, it shall be modified as appropriate to protect the Company Group’s interests and the revised covenants and clauses shall be enforced in accordance with the tenor of the Agreement. In the event a court should determine not to enforce a covenant as written due to overbreadth, the parties specifically agree that said covenant shall be enforced to the extent reasonable, whether said revisions are in time, territory or scope of prohibited activities. The parties agree that the covenants contained in this Agreement are severable and divisible; that none of such covenants depends on any other
4


covenant for its enforceability; that such covenants constitute enforceable obligations between the parties; that each such covenant will be construed as an agreement independent of any other covenant of this Agreement; and that the existence of any claim or cause of action by one party to this Agreement against the other party to this Agreement, whether predicated on this Agreement or otherwise, will not constitute a defense to the enforcement by any party to this Agreement of any such covenant.
6.    Delivery of Shares.
Within a reasonable time after the vesting of any Restricted Share Units (whether such vesting occurs as a result of Grantee’s employment on the Vesting Date or Grantee’s earlier termination of employment pursuant to Section 3(c) or (d)) and in no event later than two and one-half months after the later of (i) the end of the calendar year in which such Restricted Share Units fully vest and are no longer subject to forfeiture and (ii) the end of the Company’s fiscal year in which such Restricted Share Units fully vest and are no longer subject to forfeiture, the Company shall deliver a number of Shares equal to the number of vested Restricted Share Units; provided, however, that the Committee may elect to make payment in cash equal to the Fair Market Value of the Shares, or in a combination of cash and Shares. Grantee may not sell, assign, transfer or pledge any right or interest in the Restricted Share Units prior to the date on which payment or delivery in respect of such Restricted Share Units has been made.
7.    Acknowledgment of Grantee.
Grantee acknowledges that certain restrictions under state, federal or foreign securities laws may apply with respect to the Shares issued pursuant to the Award. Grantee further acknowledges that, to the extent Grantee is an “affiliate” of the Company (as that term is defined by the Securities Act of 1933), the Shares issued as a result of the Award are subject to certain trading restrictions under applicable securities laws (including, particularly, Rule 144 under the Securities Act). Grantee hereby agrees to execute such documents and take such actions as the Company may reasonably require with respect to state, federal and foreign securities laws applicable to the Company and any restrictions on the resale of such Shares which may pertain under such laws. The Company has registered (or intends to register) the securities represented by the Restricted Share Units; however, in the event such registration at any time is ineffective or any special rules apply, such securities may be sold or transferred only in accordance with the Plan and pursuant to additional, effective securities laws registrations or in a transaction that is exempt from such registration requirements. If appropriate under the circumstances, the certificate(s) evidencing the Restricted Share Units shall bear a restrictive legend indicating that such share units have not been registered under applicable securities laws.
8.    Execution of Agreement.
Grantee shall execute this Agreement within 30 days after receipt of same, and promptly return an executed copy to the Secretary of the Company.
9.    Withholding.
Grantee shall pay the Company an amount equal to the sum of all applicable employment taxes that the Company or any Subsidiary is required to withhold at any time in connection with the operation of this Agreement. In the absence of prior arrangements satisfactory to the Company for payment of all such taxes required to be withheld, the Company shall withhold a portion of the Shares issuable with respect to Restricted Share Units under this Agreement in payment of such taxes, except to the extent such withholding of Shares is prohibited by any covenants governing the Company’s debt as in effect from time to time.
5


10.    Miscellaneous.
(a)    Employment Rights. The granting of the Award and the execution of this Agreement shall not afford Grantee any rights to similar grants in future years or any right to be retained in the employ or service of the Company or any of its Subsidiaries, nor shall it interfere in any way with the right of the Company or any such Subsidiary to terminate Grantee's employment or services at any time, with or without cause, or the right of Grantee to terminate Grantee’s employment or services at any time.
(b)    Shareholder Rights. Prior to the date on which Shares in respect of vested Restricted Share Units are delivered to Grantee in accordance with Section 6, Grantee shall not have any rights of a shareholder of the Company with respect to any of the Shares represented by the Restricted Share Units, including the right to vote the Shares and to receive any cash dividends.
(c)    Severability. If any term, provision, covenant or restriction contained in this Agreement is held by a court or a governmental agency of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions contained in this Agreement shall continue in full force and effect, and shall in no way be affected, impaired or invalidated.
(d)    Controlling Law. This Agreement is being made in the State of Georgia (USA) and shall be construed and enforced in accordance with the laws of that state. Grantee hereby consents to the exclusive jurisdiction of the Superior Court of Fulton County, Georgia, and the U.S. District Court in Atlanta, Georgia, and hereby waives any objection Grantee might otherwise have to jurisdiction and venue in such courts, in the event either court is requested to resolve a dispute between the parties with respect to this Agreement.
(e)    Section 409A. The provisions of this Agreement are intended to be exempt from Section 409A and shall be construed accordingly.
(f)    Construction. This Agreement contains the entire understanding between the parties and supersedes any prior understanding and agreements between them with respect to the subject matter hereof. There are no representations, agreements, arrangements or understandings, oral or written, between the parties hereto relating to the subject matter hereof which are not fully expressed herein.
(g)    Binding Effect. This Agreement shall inure to the benefit of, and be binding upon, the Company and its successors and assigns, and Grantee and Grantee’s heirs and personal representatives. Any business entity or person succeeding to all or substantially all of the business of the Company by stock purchase, merger, consolidation, purchase of assets, or otherwise shall be bound by and shall adopt and assume this Agreement, and the Company shall obtain the assumption of this Agreement by such successor.
(h)    Headings. Section and other headings contained in this Agreement are included for reference purposes only and are in no way intended to define or limit the scope, extent or intent of this Agreement or any provision hereof.
6


IN WITNESS WHEREOF, the individual party hereto has executed this Agreement, and the corporate party has caused this Agreement to be executed by a duly authorized representative, as of the date first set forth above.
INTERFACE, INC.
By:______________________________________
[Name]
[Title]
    
GRANTEE
__________________________________________

[Name]


7

INTERFACE, INC.
PERFORMANCE SHARE AGREEMENT
This Performance Share Agreement (this “Agreement”) is entered into as of the ____ day of _________ 202_, by and between Interface, Inc. (the “Company”) and _________________ (“Grantee”).
W I T N E S S E T H:
WHEREAS, the Company has adopted the Interface, Inc. 2020 Omnibus Stock Incentive Plan (the “Plan”) which is administered by a committee appointed by the Company’s Board of Directors (the “Committee”); and
WHEREAS, the Committee has granted to Grantee an award of Performance Shares under the terms of the Plan (the “Award”) to encourage Grantee’s continued loyalty and diligence; and
WHEREAS, to comply with the terms of the Plan and to further the interests of the Company and Grantee, the parties hereto have set forth the terms of the Award in writing in this Agreement.
NOW, THEREFORE, for and in consideration of the mutual promises herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
1)    Plan Provisions.
In addition to the terms and conditions set forth herein, the Award is subject to and governed by the terms and conditions set forth in the Plan, which are hereby incorporated herein by reference. Any terms used herein with an initial capital letter shall have the same meaning as provided in the Plan, unless otherwise specified herein. In the event of any conflict between the provisions of this Agreement and the Plan, the Plan shall control.
2)    Performance Share Award.
(a)    Effective on _________ __, 202_ (the “Grant Date”), and subject to the restrictions and other conditions set forth herein, the Committee granted to Grantee an Award of _____________ Performance Shares, representing shares of common stock, $.10 par value per share, of the Company (“Shares”), based on a “Target Level” of performance attainment as described in Section 3 below. Such Performance Shares granted are hereinafter sometimes referred to as the “Performance Shares.” The Fair Market Value of each Performance Share awarded on the Grant Date was $_______.
(b)    If cash dividends are paid with respect to Shares, Grantee shall be credited with a “dividend equivalent” representing the right to receive a cash payment equal to the amount of such dividend with respect of each Performance Share remaining subject to the Award. If dividends are paid in the form of Shares rather than cash, then the number of Performance Shares remaining subject to the Award shall be increased by the number of Shares that would have been received as a dividend had such Performance Shares been outstanding Shares. Dividend equivalents and additional Performance Shares credited under this Section shall vest or be forfeited on the same terms as, and shall be payable as soon as reasonably practicable after, the date on which Shares are distributed to Grantee in respect of the related Performance Shares.



3)    Performance and Vesting Restrictions.
(a)    General. All or a portion (as applicable) of the Performance Shares will vest and no longer be subject to forfeiture if one or more of several criteria is satisfied. As described below, these criteria are based on _________________________________________, the termination of Grantee’s employment after the occurrence of a Change in Control (as defined in Section 4(d) hereof), and/or certain other events resulting in termination of Grantee’s employment with the Company as described in Section 4 hereof. _______________________________ will be measured over a period of three fiscal years of the Company commencing with the fiscal year beginning on ____________ __, 202_ (the “Performance Period”). Except as provided in Section 4 below, no Performance Shares shall vest and no Shares shall be delivered to Grantee unless Grantee is continuously employed by the Company or any of its Subsidiaries through the date on which the Committee certifies the _______________________________ for the Performance Period (the “Vesting Date”).
(b)    Performance Vesting. [Performance Vesting Criteria Described Here]
(c)    Performance Vesting. [Any Additional Performance Vesting Criteria Described Here]
(d)    Effect of a Change in Control. In the event of a Change in Control (as defined in Section 4(d)), the Committee shall have the authority to, without the Grantee’s consent, alter or amend the terms of the Award, with respect to any Performance Shares that have not then vested or been forfeited, in any manner that it deems equitable and necessary or advisable, in its sole discretion, to take into account the effect of the Change in Control. Such modifications may include, by way of example and not by way of limitation, (i) providing for payment in the form of cash or other securities in lieu of Shares, (ii) vesting of all or a portion of the Performance Shares based on the attainment of the performance criteria under Section 3(b) or 3(c) determined as of the date of the Change of Control, (iii) accelerating the vesting of the Performance Shares in full or on a pro rata basis, (iv) converting some or all of the Performance Shares to time-based vesting, or (v) making appropriate adjustments to the performance criteria under Sections 3(b) and 3(c). Nothing in this Section 3(d) shall limit the Committee from taking any other action permitted under the Plan with respect to the Performance Shares.
4)    Effect of Termination of Employment
(a)    Resignation or Termination for Cause. If Grantee voluntarily resigns from employment with the Company and all of its Subsidiaries for any reason other than Disability (as defined in subsection (b) below) or Retirement (as defined in subsection (c) below) prior to the Vesting Date, or if the Company or the Subsidiary that is Grantee’s employer terminates Grantee’s employment for Cause (as defined below) prior to the Vesting Date, and the provisions of Section 4(d) do not apply, all Performance Shares shall be immediately forfeited, and Grantee shall have no rights in such Performance Shares. For purposes hereof, the term “Cause” shall mean the reason for termination of Grantee’s employment is (A) Grantee’s fraud, dishonesty, gross negligence or willful misconduct, with respect to the business affairs of the Company or its Subsidiaries, (B) Grantee’s refusal or repeated failure to follow the established lawful policies of the Company or its Subsidiaries applicable to persons occupying the same or similar positions, or (C) Grantee’s conviction of a felony or other crime involving moral turpitude.
(b)    Disability or Death. If Grantee’s employment with the Company and its Subsidiaries terminates prior to the Vesting Date as a result of (i) Grantee’s Disability (as defined below) or (ii) Grantee’s death, Grantee (or Grantee’s heirs) shall retain a pro rata portion of the Performance Shares, which shall become vested as of the Vesting Date pursuant to Section 3 (but
- 2 -


only to the extent the Committee has certified the performance attainment of _______________________________. The number of Performance Shares retained will be equal to the product of (x) the total number of Performance Shares granted hereunder, and (y) a fraction, the numerator of which is the number of full and partial 12-month periods that have elapsed since the Grant Date (with any partial 12-month period treated as a whole 12-month period), and denominator of which is three. Any Performance Shares that do not vest as described herein shall be forfeited, and Grantee (or Grantee’s heirs) shall not have any rights in such Performance Shares. For purposes hereof, the term “Disability” shall mean Grantee’s inability, as a result of physical or mental incapacity, to substantially perform Grantee’s duties for the Company and its Subsidiaries on a full-time basis for a continuous period of six months. The Committee, in its sole discretion, shall make all determinations as to whether or not Grantee has incurred a Disability, and the Committee’s determination shall be final and binding.
(c)    Retirement or Involuntary Termination. If Grantee’s employment with the Company and its Subsidiaries terminates prior to the Vesting Date as a result of (i) Grantee’s Retirement (as defined below), or (ii) Grantee’s involuntary termination by or at the request of the Company (or the Subsidiary that is Grantee’s employer) for any reason other than Cause (as defined in subsection (a) above), and the provisions of Section 4(d) do not apply, Grantee shall retain a pro rata portion of the Performance Shares, which shall become vested as of the Vesting Date pursuant to Section 3 (but only to the extent the Committee has certified the performance attainment of _______________________________ for the Performance Period); provided, however, that, in the case of Grantee’s involuntary termination, in order to receive such Performance Shares, Grantee must sign and not revoke a release of claims and acknowledgement in the form required by the Company. The number of Performance Shares retained will be equal to the product of (x) the total number of Performance Shares granted hereunder, and (y) a fraction, the numerator of which is the number of full and partial 12-month periods that have elapsed since the Grant Date (with any partial 12-month period treated as a whole 12-month period), and denominator of which is three. Any Performance Shares that do not vest as described herein shall be forfeited, and Grantee shall not have any rights in such Performance Shares. For purposes hereof, the term “Retirement” shall mean Grantee’s termination of employment with the Company and its Subsidiaries for any reason, other than termination by the Company for Cause, after (i) Grantee has attained age 58 and (ii) the total of Grantee’s age and completed years of service with the Company and its subsidiaries equals at least 75. Age and years of service will be in whole years as of the separation date, and years of service will be based on Grantee’s “Years of Vesting Service” determined under the Interface, Inc. Savings and Investment Plan. Notwithstanding the foregoing, Grantee will be considered to have terminated due to Retirement only if Grantee (i) has not already been notified by the Company that Grantee’s employment is being involuntarily terminated within the next six (6) months and, (ii) provides at least 90 days of advance written notice to the Company, unless a shorter period of notice is accepted by the Committee.
(d)    Termination After a Change in Control. If, within 24 months following the occurrence of a Change in Control (as defined below) and prior to the Vesting Date, Grantee’s employment with the Company and its Subsidiaries terminates as a result of (i) involuntary termination by or at the request of the Company (or the Subsidiary that is Grantee’s employer) for any reason other than Cause (as defined in Section 4(a)), or (ii) a voluntary termination by Grantee with Good Reason (as defined below), Grantee shall vest in and be entitled to receive the nominal number of Performance Shares set forth in Section 2(a). Any Performance Shares that do not vest as described herein shall be immediately forfeited, and Grantee shall not have any rights in such Performance Shares. For purposes hereof, “Change in Control” shall mean the earliest to occur of:
(i)    the acquisition by any “person”, entity, or “group” of “beneficial ownership” (as such terms are used in Sections 13(d) and 14(d) of the Securities
- 3 -


Exchange Act of 1934, and rules promulgated thereunder) of more than 30 percent of the outstanding capital stock entitled to vote for the election of directors (“Voting Stock”) of (A) the Company, or (B) any corporation which is the surviving or resulting corporation, or the transferee corporation, in a transaction described in clause (ii)(A) or (ii)(B) immediately below;
(ii)    the effective time of (A) a merger, consolidation or other business combination of the Company with one or more corporations as a result of which the holders of the outstanding Voting Stock of the Company immediately prior to such merger or consolidation hold less than 51 percent of the Voting Stock of the surviving or resulting corporation, or (B) a transfer of all or substantially all of the property or assets of the Company other than to an entity of which the Company owns at least 51 percent of the Voting Stock, or (C) a plan of complete liquidation of the Company; and
(iii)    the election to the Board of Directors of the Company, without the recommendation or approval of the incumbent Board of Directors, of directors constituting a majority of the number of directors of the Company then in office.
Good Reason” shall mean, following a Change in Control, (i) a material reduction in Grantee’s authorities, duties or responsibilities, (ii) a material reduction in Grantee’s base compensation or bonus opportunity as in effect immediately prior to the Change in Control, (iii) a material reduction in Grantee’s benefits, other than a reduction affecting substantially all similarly situated employees, (iv) a material reduction in any budget over which the Grantee has authority, or (v) a Company-required relocation of more than 30 miles of the Grantee’s principal place of employment. An event described in clause (i), (ii) or (iii) shall constitute Good Reason only if the Grantee notifies the Company within 20 days of the occurrence of the event and the Company fails to take appropriate action to cure such event within 20 days after receiving such notice.
5)    Delivery of Shares.
        Within a reasonable time after the vesting of any Performance Shares (whether such vesting occurs pursuant to Section 3(b), 3(c), 3(d) or 4(d)) and in no event later than two and one-half months after the later of (i) the end of the calendar year in which such Performance Shares fully vest and are no longer subject to forfeiture and (ii) the end of the Company’s fiscal year in which such Performance Shares fully vest and are no longer subject to forfeiture, the Company shall deliver a number of Shares equal to the number of vested Performance Shares; provided, however, that the Committee may elect to make payment in cash equal to the Fair Market Value of the Shares, or in a combination of cash and Shares. Notwithstanding anything in the Plan to the contrary, the distribution of shares in respect of Performance Shares vesting pursuant to Section 3(b) or 3(c) shall be subject to the Committee’s certification of attainment of _______________________________ for the Performance Period. Grantee may not sell, assign, transfer or pledge any right or interest in the Performance Shares prior to the date on which payment or delivery in respect of such Performance Shares has been made.
6)    Limitations on Post-Termination Activities.
During the term of Grantee’s employment by the Company or any of its direct or indirect subsidiaries (collectively, the “Company Group”), and for a period of 12 months thereafter, Grantee will not (i) provide any “Services” within the geographic territory of the business unit with whom Grantee is employed at the time of termination (whether Americas, EMEA or Asia-Pacific, as applicable, or, for corporate employees, all such geographic regions) to any person or entity (other than the Company Group) developing, manufacturing, marketing, selling, distributing (including, without limitation, through catalogs and similar instruments),
- 4 -


installing, maintaining or reclaiming any carpet tile (also known as modular carpeting), broadloom carpet (whether 12-foot, six-foot or other competitive widths), luxury vinyl tile, rubber flooring, or other flooring for contract, commercial, institutional (including, without limitation, government and education), healthcare, transportation, life sciences, retail, hospitality or residential markets and customers, (ii) solicit, initiate contact with, call upon, initiate communication with or attempt to initiate communication with, directly or indirectly, any customer of the Company Group with whom Grantee had material contact within the most recent two years of Grantee’s employment, or any representative of any such customer, with a view to providing Services to such customers, or (iii) solicit or attempt to solicit, directly or indirectly, for employment with another person or entity a Company Group employee with whom Grantee had material contact during the most recent two years of Grantee’s employment. As used herein, “Services” shall mean the services which are the same as or substantially similar to the services Grantee provides to any Company Group entity within the most recent two years of Grantee’s employment, and that Grantee shall be prohibited from providing (whether as an owner, partner, employee, consultant or in any other capacity) in competition with any Company Group entity, in accordance with the terms of this paragraph, which include but are not limited to conducting the business of developing, manufacturing, marketing, selling, distributing, installing, maintaining or reclaiming any carpet tile, broadloom carpet, luxury vinyl tile, rubber flooring, or other flooring. During the term of Grantee’s employment by the Company Group, and for a period of 12 months thereafter, Grantee shall, before accepting employment with another employer, provide such prospective employer with a copy of this Section 6 of this Agreement and, upon accepting any employment with another employer, provide the Company with such employer’s name and a description of the services Grantee will provide to such employer. Upon any termination of Grantee’s employment for any reason whatsoever (whether voluntary on the part of Grantee, for just cause, without just cause, or for other reasons), the obligations of Grantee pursuant to this Section 6 shall survive and remain in effect.
The parties acknowledge and agree that (i) the covenants contained in this Section 6 are reasonable and necessary for the protection of the business and goodwill of the Company Group, (ii) any breach of the covenants in this Section 6 by Grantee will cause the Company Group substantial and irreparable harm, and (iii) Grantee has received good, valuable and adequate consideration in exchange for the covenants contained in this Section 6. Consequently, if the Grantee breaches any of the terms of this Section 6, the Grantee will forfeit the award described in this Agreement and all rights hereunder. The Company Group shall also be entitled to seek, in addition to other available remedies, a temporary or permanent injunction or other equitable relief against such breach or threatened breach from any court of competent jurisdiction, without the necessity of showing any actual damages or that money damages would not afford an adequate remedy, and without the necessity of posting any bond or other security. Such equitable relief will be in addition to, not in lieu of, legal remedies, monetary damages or other available forms of relief.
The covenants contained in this Section 6 shall be presumed to be enforceable, and any reading causing unenforceability shall yield to a construction permitting enforcement. If any single covenant or clause shall be found unreasonable, unenforceable or both, it shall be modified as appropriate to protect the Company Group’s interests and the revised covenants and clauses shall be enforced in accordance with the tenor of the Agreement. In the event a court should determine not to enforce a covenant as written due to overbreadth, the parties specifically agree that said covenant shall be enforced to the extent reasonable, whether said revisions are in time, territory or scope of prohibited activities. The parties agree that the covenants contained in this Agreement are severable and divisible; that none of such covenants depends on any other covenant for its enforceability; that such covenants constitute enforceable obligations between the parties; that each such covenant will be construed as an agreement independent of any other covenant of this Agreement; and that the existence of any claim or cause of action by one party to this Agreement against the other party to this Agreement, whether predicated on this
- 5 -


Agreement or otherwise, will not constitute a defense to the enforcement by any party to this Agreement of any such covenant.
    7)    Acknowledgment of Grantee.
Grantee acknowledges that certain restrictions under state, federal or foreign securities laws may apply with respect to the Performance Shares granted pursuant to the Award. Grantee further acknowledges that, to the extent Grantee is an “affiliate” of the Company (as that term is defined by the Securities Act of 1933), the Shares issued under the Award are subject to certain trading restrictions under applicable securities laws (including, particularly, Rule 144 under the Securities Act). Grantee hereby agrees to execute such documents and take such actions as the Company may reasonably require with respect to state, federal and foreign securities laws applicable to the Company and any restrictions on the resale of the Shares delivered in respect of such Performance Shares which may pertain under such laws. The Company has registered (or intends to register) the Shares represented by the Performance Shares; however, in the event such registration at any time is ineffective or any special rules apply, such securities may be sold or transferred only in accordance with the Plan and pursuant to additional, effective securities laws registrations or in a transaction that is exempt from such registration requirements. If appropriate under the circumstances, the certificate(s) evidencing such Shares shall bear a restrictive legend indicating that such shares have not been registered under applicable securities laws.
8)    Execution of Agreement.
Grantee shall execute this Agreement within 30 days after receipt of same, and promptly return an executed copy to the Secretary of the Company.
9)    Withholding.
Grantee shall pay the Company an amount equal to the sum of all applicable employment taxes that the Company or any Subsidiary is required to withhold at any time in connection with the operation of this Agreement. In the absence of prior arrangements satisfactory to the Company for payment of all such taxes required to be withheld, the Company shall withhold a portion of the Shares or cash to be delivered under this Agreement in payment of such taxes, except to the extent such withholding of Shares is prohibited by any covenants governing the Company’s debt as in effect from time to time.
10)    Miscellaneous.
a)    Employment Rights. The granting of the Award and the execution of this Agreement shall not afford Grantee any rights to similar grants in future years or any right to be retained in the employ or service of the Company or any of its Subsidiaries, nor shall it interfere in any way with the right of the Company or any such Subsidiary to terminate Grantee’s employment or services at any time, with or without cause, or the right of Grantee to terminate Grantee’s employment or services at any time.
b)    Shareholder Rights. Prior to the delivery of Shares pursuant to Section 5, Grantee shall not have the rights of a shareholder of the Company with respect to any of the Shares potentially represented by the Performance Shares, including the right to vote such Shares or to receive any cash dividends.
c)    Severability. If any term, provision, covenant or restriction contained in this Agreement is held by a court or a governmental agency of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions
- 6 -


contained in this Agreement shall continue in full force and effect, and shall in no way be affected, impaired or invalidated.
d)    Controlling Law. This Agreement is being made in the State of Georgia (USA) and shall be construed and enforced in accordance with the laws of that state. Grantee hereby consents to the exclusive jurisdiction of the Superior Court of Fulton County, Georgia, and the U.S. District Court in Atlanta, Georgia, and hereby waives any objection Grantee might otherwise have to jurisdiction and venue in such courts, in the event either court is requested to resolve a dispute between the parties with respect to this Agreement.
e)    Section 409A. The provisions of this Agreement are intended to be exempt from Section 409A and shall be construed accordingly.
f)    Construction. This Agreement contains the entire understanding between the parties and supersedes any prior understanding and agreements between them with respect to the subject matter hereof. There are no representations, agreements, arrangements or understandings, oral or written, between the parties hereto relating to the subject matter hereof which are not fully expressed herein.
g)    Binding Effect. This Agreement shall inure to the benefit of, and be binding upon, the Company and its successors and assigns, and Grantee and Grantee’s heirs and personal representatives. Any business entity or person succeeding to all or substantially all of the business of the Company by stock purchase, merger, consolidation, purchase of assets, or otherwise shall be bound by and shall adopt and assume this Agreement, and the Company shall obtain the assumption of this Agreement by such successor.
h)    Headings. Section and other headings contained in this Agreement are included for reference purposes only and are in no way intended to define or limit the scope, extent or intent of this Agreement or any provision hereof.
IN WITNESS WHEREOF, the individual party hereto has executed this Agreement, and the corporate party has caused this Agreement to be executed by a duly authorized representative, as of the date first set forth above.
INTERFACE, INC.
By:________________________________________
[Name]
[Title]

GRANTEE
____________________________________
[Name]

image_0.jpg

- 7 -

Exhibit 31.1 
CERTIFICATION 
I, Laurel M. Hurd, certify that: 
1.I have reviewed this quarterly report on Form 10-Q of Interface, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: 5/9/2023
/s/ Laurel M. Hurd
Laurel M. Hurd
Chief Executive Officer


Exhibit 31.2
CERTIFICATION
I, Bruce A. Hausmann, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Interface, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
  
Date: 5/9/2023 
 /s/ Bruce A. Hausmann
 Bruce A. Hausmann
 Chief Financial Officer



Exhibit 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
 
I, Laurel M. Hurd, Chief Executive Officer of Interface, Inc. (the “Company”), certify, pursuant to 18 U.S.C. § 1350 as adopted by § 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)the Quarterly Report on Form 10-Q of the Company for the quarterly period ended April 2, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
  
Date: 5/9/2023 
 /s/ Laurel M. Hurd
 Laurel M. Hurd
 Chief Executive Officer



Exhibit 32.2
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
 
I, Bruce A. Hausmann, Chief Financial Officer of Interface, Inc. (the “Company”), certify, pursuant to 18 U.S.C. § 1350 as adopted by § 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)the Quarterly Report on Form 10-Q of the Company for the quarterly period ended April 2, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
  
Date: 5/9/2023 
 /s/ Bruce A. Hausmann
 Bruce A. Hausmann
 Chief Financial Officer